Almost Family (AFAM) Inactive 10-K27 Feb 152014 FY Annual reportFinancial data

Company Profile

Document_and_Entity_Informatio

Document and Entity Information (USD $)	12 Months Ended
Document and Entity Information (USD $)	Dec. 31, 2014	Feb. 24, 2015	Jun. 30, 2014
Document and Entity Information
Entity Registrant Name	ALMOST FAMILY INC
Entity Central Index Key	799231
Document Type	10-K
Document Period End Date	31-Dec-14
Amendment Flag	FALSE
Current Fiscal Year End Date	-19
Entity Well-known Seasoned Issuer	No
Entity Voluntary Filers	No
Entity Current Reporting Status	Yes
Entity Filer Category	Accelerated Filer
Entity Public Float			$186,146,787
Entity Common Stock, Shares Outstanding		9,480,331
Document Fiscal Year Focus	2014
Document Fiscal Period Focus	FY

CONSOLIDATED_STATEMENTS_OF_INC

CONSOLIDATED STATEMENTS OF INCOME (USD $)	12 Months Ended
In Thousands, except Per Share data, unless otherwise specified	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012
CONSOLIDATED STATEMENTS OF INCOME
Net service revenues	$495,829	$356,912	$340,620
Cost of service revenues (excluding depreciation & amortization)	263,994	190,548	176,683
Gross margin	231,835	166,364	163,937
General and administrative expenses:
Salaries and benefits	141,359	102,498	95,975
Other	60,522	44,750	39,421
Deal, transition and other non-recurring cots	5,312	4,323	588
Total general and administrative expenses	207,193	151,571	135,984
Operating income	24,642	14,793	27,953
Interest expense, net	-1,435	-167	-104
Income before income taxes	23,207	14,626	27,849
Income tax expense	-9,511	-6,020	-11,047
Net income from continuing operations	13,696	8,606	16,802
Discontinued operations:
(Loss) gain from operations, net of tax of ($121), $882, and $108	-172	-729	482
Gain on sale, net of tax of $973		171
(Loss) gain on discontinued operations	-172	-558	482
Net income	13,524	8,048	17,284
Net loss attributable to noncontrolling interest	239	178
Net Income attributable to Almost Family, Inc.	$13,763	$8,226	$17,284
Per share amounts-basic:
Average shares outstanding (in shares)	9,333	9,279	9,285
Income from continued operations attributable to Almost Family, Inc.	$1.49	$0.95	$1.81
Discontinued operation (in dollars per share)	($0.02)	($0.06)	$0.05
Net income attributable to Almost Family, Inc. (in dollars per share)	$1.47	$0.89	$1.86
Per share amounts-diluted:
Average shares outstanding (in shares)	9,462	9,374	9,324
Income from continued operations attributable to Almost Family, Inc.	$1.47	$0.94	$1.80
Discontinued operation (in dollars per share)	($0.02)	($0.06)	$0.05
Net income attributable to Almost Family, Inc. (in dollars per share)	$1.45	$0.88	$1.85

CONSOLIDATED_STATEMENTS_OF_INC1

CONSOLIDATED STATEMENTS OF INCOME (Parenthetical) (USD $)	12 Months Ended
In Thousands, unless otherwise specified	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012
Discontinued operations:
(Loss) gain from operations, tax	($121)	$882	$108
Gain on sale, tax	$973

CONSOLIDATED_BALANCE_SHEETS

CONSOLIDATED BALANCE SHEETS (USD $)	Dec. 31, 2014	Dec. 31, 2013
In Thousands, unless otherwise specified	Dec. 31, 2014	Dec. 31, 2013
CURRENT ASSETS:
Cash and cash equivalents	$6,886	$12,246
Accounts receivable - net	74,894	59,902
Prepaid expenses and other current assets	10,420	9,854
Deferred tax assets	12,230	12,224
TOTAL CURRENT ASSETS	104,430	94,226
PROPERTY AND EQUIPMENT - NET	5,575	8,120
GOODWILL	192,523	192,489
OTHER INTANGIBLE ASSETS	54,402	53,174
OTHER ASSETS	558	775
TOTAL ASSETS	357,488	348,784
CURRENT LIABILITIES:
Accounts payable	9,257	12,057
Accrued other liabilities	42,326	42,496
Current portion - notes payable and capital leases	51	702
TOTAL CURRENT LIABILITIES	51,634	55,255
LONG-TERM LIABILITIES:
Revolving credit facility	46,447	56,000
Deferred tax liabilities	23,510	18,004
Other liabilities	2,705	1,815
TOTAL LONG-TERM LIABILITIES	72,662	75,819
TOTAL LIABILITIES	124,296	131,074
Redeemable Noncontrolling Interest, Carrying Amount
NONCONTROLLING INTEREST - REDEEMABLE - HEALTHCARE INNOVATIONS	3,639	3,639
STOCKHOLDERS' EQUITY:
Preferred stock, par value $0.05; authorized 2,000 shares; none issued or outstanding
Common stock, par value $0.10; authorized 25,000; 9,574 and 9,500 issued and outstanding	957	950
Treasury stock, at cost, 94 and 92 shares	-2,392	-2,340
Additional paid-in capital	105,862	103,858
Noncontrolling interest - nonredeemable	-420	-186
Retained earnings	125,546	111,789
TOTAL STOCKHOLDERS' EQUITY	229,553	214,071
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY	$357,488	$348,784

CONSOLIDATED_BALANCE_SHEETS_Pa

CONSOLIDATED BALANCE SHEETS (Parenthetical) (USD $)	Dec. 31, 2014	Dec. 31, 2013
In Thousands, except Per Share data, unless otherwise specified	Dec. 31, 2014	Dec. 31, 2013
CONSOLIDATED BALANCE SHEETS
Preferred stock, par value (in dollars per share)	$0.05	$0.05
Preferred stock, authorized shares	2,000	2,000
Preferred stock, issued shares	0	0
Preferred stock, outstanding shares	0	0
Common stock, par value (in dollars per share)	$0.10	$0.10
Common stock, authorized shares	25,000	25,000
Common stock, issued shares	9,574	9,500
Common stock, outstanding shares	9,574	9,500
Treasury stock, shares	94	92

CONSOLIDATED_STATEMENTS_OF_STO

CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (USD $)	Common Stock	Treasury Stock	Additional Paid-in Capital	Retained Earnings	Non-controlling Interest - Redeemable	Non-controlling Interest - Redeemable	Total
In Thousands, unless otherwise specified	Common Stock	Treasury Stock	Additional Paid-in Capital	Retained Earnings	Non-controlling Interest - Redeemable	Non-controlling Interest - Redeemable	Total
Stockholders' Equity Attributable to Parent, Beginning Balance at Dec. 31, 2011	$938	($431)	$100,678	$105,112			$206,297
Balance (in shares) at Dec. 31, 2011	9,381	-13
Increase (Decrease) in Stockholders' Equity
Options exercised, Stock award maturities, net of shares surrendered or withheld	1		69				70
Options exercised, Stock award maturities, net of shares surrendered or withheld (in shares)	11
Share awards and related compensation	3	-1,889	1,471				-415
Share awards and related compensation (in shares)	29	-78
Special dividend				-18,648			-18,648
Tax gain (loss) from stock-based compensation			-273				-273
Net income attributable to Almost Family, Inc.				17,284			17,284
Stockholders' Equity Attributable to Parent, Ending Balance at Dec. 31, 2012	942	-2,320	101,945	103,748			204,315
Balance (in shares) at Dec. 31, 2012	9,421	-91
Increase (Decrease) in Stockholders' Equity
Options exercised, Stock award maturities, net of shares surrendered or withheld	1	-20	17				-2
Options exercised, Stock award maturities, net of shares surrendered or withheld (in shares)	1	-1
Share awards and related compensation	5		1,460				1,465
Share awards and related compensation (in shares)	52
Tax gain (loss) from stock-based compensation			-62				-62
Stock provided in acquisitions	2		498				500
Stock provided in acquisitions	26
Acquired noncontrolling interest					-193	3,639	-193
Net loss noncontrolling interests - redeemable						-185
Noncontrolling Interests - redeemable fair value accretion				-185		185	-185
Net loss noncontrolling interests - nonredeemable					7		7
Net income attributable to Almost Family, Inc.				8,226			8,226
Stockholders' Equity Attributable to Parent, Ending Balance at Dec. 31, 2013	950	-2,340	103,858	111,789	-186	3,639	214,071
Balance (in shares) at Dec. 31, 2013	9,500	-92					9,500
Increase (Decrease) in Stockholders' Equity
Options exercised, Stock award maturities, net of shares surrendered or withheld	1	-52	156				105
Options exercised, Stock award maturities, net of shares surrendered or withheld (in shares)	14	-2
Share awards and related compensation	6		1,808				1,814
Share awards and related compensation (in shares)	60
Tax gain (loss) from stock-based compensation			40				40
Net loss noncontrolling interests - redeemable						-6
Noncontrolling Interests - redeemable fair value accretion				-6		6	-6
Net loss noncontrolling interests - nonredeemable					-234		-234
Net income attributable to Almost Family, Inc.				13,763			13,763
Stockholders' Equity Attributable to Parent, Ending Balance at Dec. 31, 2014	$957	($2,392)	$105,862	$125,546	($420)	$3,639	$229,553
Balance (in shares) at Dec. 31, 2014	9,574	-94					9,574

CONSOLIDATED_STATEMENTS_OF_CAS

CONSOLIDATED STATEMENTS OF CASH FLOWS (USD $)	12 Months Ended
In Thousands, unless otherwise specified	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012
Cash flows from operating activities:
Net income	$13,524	$8,048	$17,284
(Loss) gain on discontinued operations, net of tax	-172	-558	482
Net income from continuing operations	13,696	8,606	16,802
Adjustments to reconcile income to net cash provided by operating activities:
Depreciation and amortization	4,103	2,862	2,552
Provision for uncollectible accounts	9,413	5,378	2,761
Stock-based compensation	1,814	1,465	1,473
Deferred income taxes	5,500	2,099	3,753
Net cash provided by operating activities	34,526	20,410	27,341
Change in certain net assets and liabilities, net of the effects of acquisitions:
Accounts receivable	-24,824	-4,440	-8,708
Prepaid expenses and other current assets	-824	4,229	-1,129
Other assets	215	235	228
Accounts payable and accrued expenses	-2,431	-888	-1,705
Net cash provided by operating activities	6,662	19,546	16,027
Cash flows from investing activities:
Capital expenditures	-1,232	-2,502	-2,427
Acquisitions, net of cash acquired	-969	-88,465	-536
Net cash used in investing activities	-2,201	-90,967	-2,963
Cash flows from financing activities:
Credit facility (repayments) borrowings	-9,553	56,000
Proceeds from stock options exercises	156	11	70
Purchase of common stock in connection with share awards	-52	-20	-1,889
Tax impact of share awards	-40	62
Payment of special dividend	-35		-18,562
Principal payments on notes payable and capital leases	-702	-720	-1,200
Net cash (used in) provided by financing activities	-10,146	55,209	-21,581
Cash flows from discontinued operations:
Operating activities	323	-742	1,004
Investing activities	2	3,080	-60
Net cash from discontinued operations	325	2,338	944
Net change in cash and cash equivalents	-5,360	-13,874	-7,573
Cash and cash equivalents at beginning of period	12,246	26,120	33,693
Cash and cash equivalents at end of period	6,886	12,246	26,120
Supplemental disclosures of cash flow information:
Cash payment of interest, net of amounts capitalized	1,264	97	104
Cash payment of taxes	1,953	6,084	8,352
Summary of non-cash investing and financing activities:
Acquisitions funded by notes payable		1,500
Acquisitions funded by stock		500
Dividends declared, not paid			$86

SUMMARY_OF_SIGNIFICANT_ACCOUNT

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES	12 Months Ended
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES	Dec. 31, 2014
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
SUMMARY OF SIGNIFICANT ACCOUTNING POLICIES	NOTE 1 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

	Basis of Consolidation and Description Of Business

	The consolidated financial statements include the accounts of Almost Family, Inc. (a Delaware corporation) and its wholly-owned subsidiaries (collectively “Almost Family” or the “Company”). The Company is a leading, regionally focused provider of home health services and has service locations in Florida, Tennessee, Ohio, Kentucky, Connecticut, New Jersey, Massachusetts, Indiana, Illinois, Pennsylvania, Georgia, Missouri, Mississippi and Alabama (in order of revenue significance).

	The Company was incorporated in Delaware in 1985. Through a predecessor that merged into the Company in 1991, the Company has been providing health care services, primarily home health care, since 1976. All material intercompany transactions and accounts have been eliminated in consolidation.

	On December 6, 2013, the Company completed the acquisition of Omni Home Health Holdings, Inc. (“SunCrest”). Branded principally under the SunCrest name, its subsidiaries owned and operated 66 Medicare-certified home health agencies and 9 private duty agencies in Florida, Tennessee, Georgia, Pennsylvania, Kentucky, Illinois, Indiana, Mississippi and Alabama. On October 4, 2013, the Company acquired a controlling interest in Imperium Health Management, LLC (“Imperium”), a development-stage enterprise that provides strategic health management services to Accountable Care Organizations (“ACO’s”). On July 17, 2013, the Company acquired the assets of the Medicare-certified home health agencies owned by Indiana Home Care Network (“IHCN”). The acquisitions are more fully described in Note 12, “Acquisitions”. The results of operations for SunCrest and IHCN are principally reported within the Company’s Visiting Nurse reportable segment, while Imperium results are currently included the Company’s Healthcare Innovations segment. The Company’s consolidated financial statements are prepared in accordance with U.S. generally accepted accounting principles (US GAAP). All intercompany balances and transactions have been eliminated.

	New Accounting Pronouncements

	The Financial Accounting Standards Board issued Accounting Standards Update No. 2014-09, Revenue from Contracts with Customers (Topic 606), during the second quarter of 2014. Topic 606 affects virtually all aspects of an entity’s revenue recognition, including determining the measurement of revenue and the timing of when it is recognized for the transfer of goods or services to customers. Topic 606 is effective for annual reporting periods beginning after December 15, 2016. The Company is currently evaluating the effect of the adoption of Topic 606 on its financial position and results of operations.

	Cash and Cash Equivalents

	The Company considers all highly liquid debt instruments purchased with an original maturity of three months or less to be cash equivalents.

	Uninsured deposits at December 31, 2014 and 2013 were approximately $4,183 and $9,449, respectively. These amounts have been deposited with national financial institutions.

	Property and Equipment

	Property and equipment are stated at cost. Depreciation is computed using the straight-line method over the estimated useful lives (generally two to ten years for medical and office equipment and three years for internally developed software). Leasehold improvements are depreciated over the terms of the respective leases (generally three to ten years). Such costs are periodically reviewed for recoverability when impairment indicators are present. Such indicators include, among other factors, operating losses, unused capacity, market value declines and technological obsolescence. Recorded values of asset groups of property, plant and equipment that are not expected to be recovered through undiscounted future net cash flows are written down to current fair value, which generally is determined from estimated discounted future net cash flows (assets held for use) or net realizable value (assets held for sale).

	Goodwill and Other Intangible Assets

	Goodwill and indefinite lived intangible assets acquired are stated at fair value at the date of acquisition. Subsequent to acquisition, the Company conducts annual reviews for impairment, or more frequently if circumstances indicate impairment may have occurred. The Company reviews goodwill for impairment based on its identified reporting units, which are the same as its reportable segments. The Company tests goodwill for impairment by comparing the carrying value to the estimated fair value of its reporting units, determined using a combination of the market approach (guideline company and similar transaction method) and income approach (discounted cash flow analysis). The Company annually tests its indefinite-lived intangible assets, principally trade names, certificates of need, provider numbers and licenses. Specifically trade names are tested using a “relief-from-royalty” valuation method compared to the carrying value. Significant assumptions inherent in the valuation methodologies for goodwill and other intangibles are employed and include, but are not limited to, such estimates as future projected business results, growth rates, legislated changes in payment rates, weighted-average cost of capital for a market participant, royalty and discount rates. The Company has completed its most recent annual impairment tests as of December 31, 2014 and determined that no impairment existed.

	Finite-lived intangible assets are amortized on a straight-line basis over their estimated useful lives, such as the cost of non-compete agreements for which their estimated useful life is usually 3 years, beginning after the earn-out period, if any.

	The following table summarizes the activity related to the Company’s goodwill and other intangible assets:

						Other Intangible Assets
			Goodwill			Certificates			Trade			Non-compete			Total
						of Need and			Names			Agreements
						Licenses
	December 31, 2012 balance		$	133,471		$	9,391		$	10,421		$	155		$	19,967
	Acquisitions		60,475			28,930			4,370			—			33,300
	Disposals		(1,457		)	—			—			—			—
	Amortization		—			—			(10		)	(83		)	(93		)
	December 31, 2013 balance		$	192,489		$	38,321		$	14,781		$	72		$	53,174
	Acquisitions		—			1,290			—			—			1,290
	Changes		34			—			—			—			—
	Amortization		—			—			(10		)	(52		)	(62		)
	December 31, 2014 balance		$	192,523		$	39,611		$	14,771		$	20		$	54,402

	Additions were due to acquisitions (Note 12) and disposals were due to asset dispositions (Note 11).

	The following table summarizes the Company’s goodwill and other intangible assets by segment:

						Other Intangible Assets
			Goodwill			Certificates			Trade			Non-compete			Total
						of Need and			Names			Agreements
						Licenses
	Visiting Nurse		$	147,368		$	37,541		$	11,401		$	23		$	48,965
	Personal Care		37,571			780			3,380			49			4,209
	Healthcare Innovations		7,550			—			—			—			—
	December 31, 2013 balance		$	192,489		$	38,321		$	14,781		$	72		$	53,174

	Visiting Nurse		$	147,368		$	38,831		$	11,391		$	10		$	50,232
	Personal Care		37,571			780			3,380			10			4,170
	Healthcare Innovations		7,584			—			—			—			—
	December 31, 2014 balance		$	192,523		$	39,611		$	14,771		$	20		$	54,402

Capitalization Policies

Maintenance, repairs and minor replacements are charged to expense as incurred. Major renovations and replacements are capitalized to appropriate property and equipment accounts. Upon sale or retirement of property, the cost and related accumulated depreciation are eliminated from the accounts and the related gain or loss is recognized in the consolidated statement of income.

The Company capitalizes the cost of internally developed computer software for the Company’s own use. Software development costs of approximately $327, $647 and $968 were capitalized in the years ended December 31, 2014, 2013 and 2012, respectively.

Insurance Programs

The Company bears significant risk under its large-deductible workers’ compensation insurance program and its self-insured employee health program. Under the workers’ compensation insurance program, the Company bears risk up to $250 per incident, after which stop-loss coverage is maintained. The Company purchases stop-loss insurance for the employee health plan that places a specific limit, generally $300, on its exposure for any individual covered life.

Malpractice and general patient liability claims for incidents which may give rise to litigation have been asserted against the Company by various claimants. The claims are in various stages of processing and some may ultimately be brought to trial. The Company currently carries professional and general liability insurance coverage (on a claims made basis) for this exposure with no deductible. The Company also carries D&O coverage (also on a claims made basis) for potential claims against the Company’s directors and officers, including securities actions, with deductibles ranging from $100 to $200 per claim.

The Company records estimated liabilities for its insurance programs based on information provided by the third-party plan administrators, historical claims experience, the life cycle of claims, expected costs of claims incurred but not paid, and expected costs to settle unpaid claims. The Company monitors its estimated insurance-related liabilities and recoveries, if any, on a monthly basis and as required by ASU No. 2010-24, Health Care Entities (Topic 954): Presentation of Insurance Claims and Related Insurance Recoveries, records amounts due under insurance policies in other current assets, while recording the estimated carrier liability in other current liabilities. As facts change, it may become necessary to make adjustments that could be material to the Company’s results of operations and financial condition.

Accounting for Income Taxes

The Company recognizes deferred tax assets and liabilities for the expected future tax consequences of events that have been included in the financial statements or tax returns. Under this method, deferred tax assets and liabilities are determined based on the difference between the Company’s book and tax bases of assets and liabilities and tax carry-forwards using enacted tax rates in effect for the year in which the differences are expected to reverse. The effect of changes in tax rates on deferred taxes is recognized in the period in which the enactment dates change. Valuation allowances are established when necessary on a jurisdictional basis to reduce deferred tax assets to the amounts expected to be realized.

Seasonality

The Company’s VN segment operations located in Florida (which generated approximately 36% of that segment’s revenues in 2014) normally experience higher admissions during the first quarter and lower admissions during the third quarter than in the other quarters due to seasonal population fluctuations.

Net Service Revenues

The Company is paid for its services primarily by federal and state third-party reimbursement programs, commercial insurance companies, and patients. Revenues are recorded at established rates in the period during which the services are rendered. Appropriate allowances to give recognition to third party payment arrangements are recorded when the services are rendered.

Approximately 72% of the Company’s consolidated net service revenues are derived from the Medicare program. Net service revenues are recorded under the Medicare prospective payment program (PPS) based on a 60-day episode payment rate that is subject to adjustment based on certain variables including, but not limited to: (a) changes in the base episode payments established by the Medicare program; (b) adjustments to the base episode payments for case-mix and geographic wages; (c) a low utilization payment adjustment (LUPA) if the number of visits was fewer than five; (d) a partial payment if a patient is transferred to another provider or if a patient is received from another provider before completing the episode; (e) a payment adjustment based upon the level of therapy services required (thresholds set at 6, 14 and 20 visits); (f) an outlier payment if the patient’s care was unusually costly (capped at 10% of total reimbursement); (g) the number of episodes of care provided to a patient; and (h) a 2% reduction for sequestration.

At the beginning of each Medicare episode the Company calculates an estimate of the amount of expected reimbursement based on the variables outlined above and recognizes Medicare revenue on an episode-by-episode basis during the course of each episode over its expected number of visits. Over the course of each episode, as changes in the variables become known, adjustments are calculated and recorded as needed to reflect changes in expectations for that episode from those established at the start of the 60 day period until its ultimate outcome at the end of the 60 day period is known.

Substantially all remaining revenues are earned on a per visit, hour or unit basis (as opposed to episodic). For all services provided, the Company uses either payor-specific or patient-specific fee schedules for the recording of revenues at the amounts actually expected to be received.

Laws and regulations governing the Medicare and Medicaid programs are extremely complex and subject to interpretation. It is common for issues to arise related to: 1) medical coding, particularly with respect to Medicare, 2) patient eligibility, particularly related to Medicaid, and 3) other reasons unrelated to credit risk, all of which may result in adjustments to recorded revenue amounts. The Company continuously evaluates the potential for revenue adjustments and when appropriate provides allowances for losses based upon the best available information. There is at least a reasonable possibility that recorded estimates could change by material amounts in the near term. Changes in estimates related to prior periods (increased) decreased revenues by approximately ($320), $114, and $75 in the years ended December 31, 2014, 2013 and 2012, respectively.

Revenue and Receivable Concentrations

The following table sets forth the percent of the Company’s revenues generated from Medicare, state Medicaid programs and other payors for the year ended December 31:

		2014		2013		2012
Medicare		72.4	%	71.2	%	71.7	%
Medicaid & other government programs:
Ohio		8.8	%	11.7	%	11.9	%
Connecticut		5.5	%	7.1	%	6.6	%
Tennessee		2.5	%	0.2	%	0.0	%
Kentucky		1.8	%	2.3	%	2.7	%
Florida		0.6	%	0.7	%	0.5	%
Others		0.4	%	0.5	%	0.3	%
Subtotal		19.6	%	22.5	%	22.0	%
All other payors		8.0	%	6.3	%	6.3	%
Total		100.0	%	100.0	%	100.0	%

Concentrations in the Company’s accounts receivable were as follows as of December 31:

		2014					2013
		Amount			Percent		Amount			Percent
Medicare		$	46,634		55.7	%	$	42,823		56.7	%
Medicaid & other government programs:
Ohio		9,239			11	%	5,925			7.8	%
Connecticut		3,982			4.8	%	4,884			6.5	%
Kentucky		3,686			4.4	%	2,536			3.4	%
Tennessee		5,617			6.7	%	4,099			5.4	%
Others		2,835			3.4	%	1,968			2.6	%
Subtotal		25,359			30.3	%	19,412			25.7	%
All other payors		11,781			14.1	%	13,253			17.6	%
Subtotal		83,774			100	%	75,488			100	%
Allowances		(8,880		)			(15,586		)
Total		$	74,894				$	59,902

The ability of payors to meet their obligations depends upon their financial stability, future legislation and regulatory actions. The Company does not believe there are any significant credit risks associated with receivables from Federal and state third-party reimbursement programs. The allowance for uncollectible accounts principally consists of management’s estimate of amounts that may prove uncollectible for coverage, eligibility and technical reasons.

Payor Mix Concentrations and Related Aging of Accounts Receivable

The approximate breakdown by payor classification as a percent of total accounts receivable, net of contractual allowances, if any, at December 31, 2014 and 2013 is set forth in the following tables:

		2014
Payor		0-90		91-180		181-365		>1 yr.		Total
Medicare		36	%	13	%	9	%	0	%	58	%
Medicaid & Government		19	%	6	%	3	%	1	%	29	%
Self Pay		1	%	0	%	1	%	0	%	2	%
Insurance		6	%	3	%	2	%	0	%	11	%
Total		62	%	22	%	15	%	1	%	100	%

		2013
Payor		0-90		91-180		181-365		>1 yr.		Total
Medicare		30	%	12	%	5	%	3	%	50	%
Medicaid & Government		18	%	4	%	4	%	7	%	33	%
Self Pay		4	%	1	%	1	%	1	%	7	%
Insurance		4	%	1	%	2	%	3	%	10	%
Total		56	%	18	%	12	%	14	%	100	%

Variations between years are largely attributable to the SunCrest acquisition.

Allowance for Uncollectible Accounts by Payor Mix and Related Aging

The Company records an estimated allowance for uncollectible accounts by applying estimated bad debt percentages to its accounts receivable aging. The percentages to be applied by payor type are based on the Company’s historical collection and loss experience. The Company’s effective allowances for uncollectible accounts as a percent of accounts receivable were as follows at December 31, 2014 and 2013:

		2014
Payor		0-90		91-180		181-365		>1 yr.		>2 yrs.
Medicare		0	%	0	%	8	%	75	%	100	%
Medicaid & Government		1	%	8	%	31	%	66	%	100	%
Self Pay		1	%	12	%	51	%	74	%	100	%
Insurance		5	%	22	%	46	%	83	%	100	%
Total		1	%	6	%	23	%	74	%	100	%

		2013
Payor		0-90		91-180		181-365		>1 yr.		>2 yrs.
Medicare		0	%	1	%	9	%	100	%	100	%
Medicaid & Government		2	%	16	%	49	%	92	%	100	%
Self Pay		5	%	36	%	80	%	87	%	100	%
Insurance		5	%	22	%	38	%	87	%	100	%
Total		1	%	8	%	33	%	92	%	100	%

Variations between years are largely attributable to the SunCrest acquisition.

The Company’s allowance for uncollectible accounts at December 31, 2014 and 2013 was approximately $8,880 and $15,586, respectively. The increase is primarily due to the SunCrest acquisition.

Contingent Service Revenues

The Company, through its Imperium acquisition, provides strategic health management services to ACOs that have been approved to participate in the Medicare Shared Savings Program (“MSSP”). While the Company did not have ownership interests in ACO’s at December 31, 2014, it had service agreements with ACOs that provide for sharing of MSSPs received by the ACO, if any.

ACOs are entities that contract with CMS to serve the Medicare fee-for-service population with the goal of better care for individuals, improved health for populations and lower costs. ACOs share savings with CMS to the extent that the actual costs of serving assigned beneficiaries are below certain trended benchmarks of such beneficiaries and certain quality performance measures are achieved. The MSSP is relatively new and therefore has limited historical experience, which impacts the Company’s ability to accurately accumulate and interpret the data available for calculating an ACOs’ shared savings, if any. MSSP payments are not recognized in revenue until persuasive evidence of an agreement exists, services have been rendered, the payment is fixed and determinable and collectability is insured, which is generally satisfied upon cash receipt. Under such agreements, the Company recognized $1.6 million in MSSP payments for cash received during 2014 related to savings generated for the program period ended December 31, 2013, which is included in the Company’s Healthcare Innovations segment revenues. The Company has yet to recognize MSSP payments, if any, for savings generated through December 31, 2014.

Weighted Average Shares

Net income per share is presented as a unit of basic shares outstanding and diluted shares outstanding. Diluted shares outstanding is computed based on the weighted average number of common shares and common equivalent shares outstanding. Common equivalent shares result from dilutive stock options and unvested restricted shares. The following table is a reconciliation of basic to diluted shares used in the earnings per share calculation for the year ended December 31:

		2014		2013		2012
Basic weighted average outstanding shares		9,333		9,279		9,285
Dilutive effect of outstanding compensation awards		129		95		39
Diluted weighted average outstanding shares		9,462		9,374		9,324

The assumed conversions to common stock of 94, 195, and 218 of the Company’s outstanding stock options were excluded from the diluted EPS computation in 2014, 2013, and 2012, respectively, because these items, on an individual basis, have an anti-dilutive effect on diluted EPS.

Use of Estimates

The preparation of financial statements in conformity with accounting principles generally accepted in the United States requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.

Financial Statement Reclassifications

Certain prior period amounts and data have been reclassified in the financial statements and related notes in order to conform to the 2014 presentation. Such reclassifications had no effect on previously reported net income. In connection with the SunCrest acquisition, the consolidated balance sheet at December 31, 2013 has been recast to include retrospective purchase accounting adjustments. These adjustments were retrospectively applied to the December 6, 2013 acquisition date balance sheet. These adjustments pertain to measurement period adjustments during the year ended December 31, 2014, which coincides with the one year anniversary date of the acquisition, based on the valuation of assets acquired and liabilities assumed in the SunCrest acquisition. The effect on the consolidated balance sheet at December 31, 2014 is included in Note 12 to the consolidated financial statements.

Stock-Based Compensation

Stock options and restricted stock are granted under various stock compensation programs to employees and independent directors. The Company accounts for such grants in accordance with ASC Topic 718, Compensation — Stock Compensation and amortizes the fair value of awards, after estimated forfeiture, on a straight-line basis over the requisite service periods.

Accounting for Leases

The Company accounts for operating leases using the straight-line rents method, which amortizes contracted total rents due evenly over the lease term.

Advertising Costs

The Company expenses the costs of advertising as incurred. Advertising expense was $306, $326 and $316 for the years ended December 31, 2014, 2013, and 2012, respectively.

ACCRUED_LIABILITIES

ACCRUED LIABILITIES	12 Months Ended
	Dec. 31, 2014
ACCRUED LIABILITIES
ACCRUED LIABILITIES
	NOTE 2 - ACCRUED LIABILITIES

	Accrued liabilities consist of the following as of December 31:
		2014		2013
	Wages and employee benefits	$	20,084	$	20,755
	Insurance accruals	14,217		11,602
	Accrued taxes	563		1,046
	Kentucky Medicaid cost report payable	1,360		3,170
	Accrued professional fees and other	6,102		5,923
		$	42,326	$	42,496

PROPERTY_AND_EQUIPMENT_NET

PROPERTY AND EQUIPMENT, NET	12 Months Ended
	Dec. 31, 2014
PROPERTY AND EQUIPMENT, NET
PROPERTY AND EQUIPMENT, NET	NOTE 3 - PROPERTY AND EQUIPMENT, NET

	Property and equipment, net, consist of the following as of December 31:

		2014			2013
	Leasehold improvements	$	1,367		$	1,448
	Medical equipment	937			1,671
	Computer equipment	9,607			14,594
	Internally developed software	3,807			1,404
	Office and other equipment	4,502			5,071
	Vehicles	449			387
		20,669			24,575
	Less accumulated depreciation	(15,094		)	(16,455		)
		$	5,575		$	8,120

	Depreciation and amortization expense related to property, plant and equipment is recorded in general and administrative expenses - other and was $3,850, $2,594 and $2,315 for the years ended December 31, 2014, 2013 and 2012, respectively.

REVOLVING_CREDIT_FACILITY

REVOLVING CREDIT FACILITY	12 Months Ended
REVOLVING CREDIT FACILITY	Dec. 31, 2014
REVOLVING CREDIT FACILITY.
REVOLVING CREDIT FACILITY	NOTE 4 - REVOLVING CREDIT FACILITY

	On February 12, 2015, the Company entered into a new five-year $175 million revolving credit facility (the “New Facility”) which replaces the prior revolving credit facility. J.P. Morgan Securities LLC acted as lead bookrunner and arranger, while Bank of America, N.A. acted as joint lead arranger under the New Facility which replaced the Company’s previous $125 million credit facility (the “Old Facility”). The New Facility includes an accordion feature which permits expansion up to $250 million. Borrowings, other than letters of credit, under the credit facility generally will bear interest at a rate varying from LIBOR rate plus 1.75% to LIBOR rate plus 3.00%, depending on leverage. The New Facility is secured by substantially all of the Company’s assets and the stock of its subsidiaries.

	Borrowings under the New Facility are subject to various covenants including a multiple of 3.5 times earnings before interest, taxes, depreciation and amortization (“EBITDA”). EBITDA may include “Acquired EBITDA” from pro-forma acquisitions as defined. Borrowings under the New Facility may be used for general corporate purposes, including acquisitions. Application of the New Facility’s borrowing formula as of December 31, 2014, would have permitted $80.0 million to be used. We had irrevocable letters of credit totaling $7.5 million outstanding in connection with our self-insurance programs, which resulted in a total of $72.5 million being available for use at December 31, 2014. As of December 31, 2014, we were in compliance with the various financial covenants. Under the most restrictive of its covenants, we were required to maintain minimum net worth of at least $163.5 million at December 31, 2014. At such date, our net worth was approximately $229.6 million.

	At December 31, 2014, the Old Facility consisted of a $125 million credit line with a maturity date of December 2, 2015. Borrowings (other than letters of credit) under the credit facility were at either the bank’s prime rate plus a margin (ranging from 1.25% to 2.25%, currently 1.25%) or LIBOR plus a margin (ranging from 2.25% to 3.25%, currently 2.25%). The margin for prime rate or LIBOR borrowings was determined by the Company’s leverage. Borrowings under the Old Facility were secured by a first priority perfected security interest in all tangible and intangible assets of the Company, and all existing and future direct and indirect subsidiaries of the Company, as guarantors. The effective interest rates on our borrowings were 2.7% and 5.0% for 2014 and 2013, respectively.

FAIR_VALUE_MEASUREMENTS

FAIR VALUE MEASUREMENTS	12 Months Ended
FAIR VALUE MEASUREMENTS	Dec. 31, 2014
FAIR VALUE MEASUREMENTS
FAIR VALUE MEASUREMENTS	NOTE 5 - FAIR VALUE MEASUREMENTS

	The Company’s financial instruments consist of cash, accounts receivable, payables and debt instruments. Due to their short-term nature, the book values of cash, accounts receivable and payables are considered representative of their respective fair values. The fair value of the Company’s debt instruments approximates their carrying values as substantially all of such debt instruments have rates which fluctuate with changes in market rates.

	As of December 31, 2014, the Company does not have any assets or liabilities carried at fair value that are measured on a recurring basis.

INCOME_TAXES

INCOME TAXES	12 Months Ended
INCOME TAXES	Dec. 31, 2014
INCOME TAXES
INCOME TAXES	NOTE 6 - INCOME TAXES

	The provision for income taxes consists of the following as of December 31:

		2014			2013			2012
	Federal - current	$	2,829		$	3,557		$	6,113
	State and local - current	1,182			364			1,181
	Deferred	5,500			2,099			3,753
		$	9,511		$	6,020		$	11,047

	A reconciliation of the statutory to the effective rate of the Company is as follows as of December 31:

		2014		2013		2012
	Tax provision using statutory rate	35.0	%	35.0	%	35.0	%
	State and local taxes, net of Federal benefit	4.7	%	5.7	%	4.1	%
	Valuation allowance	1.0	%	-0.6	%	-0.6	%
	Noncontrolling interest related	0.4	%	0.5	%	0.0	%
	Other, net	-0.1	%	1.3	%	0.7	%
	Tax provision for continuing operations	41.0	%	41.9	%	39.2	%

	The Company has provided a valuation allowance against certain net deferred tax assets based upon management’s estimation of realizability of those assets through future taxable income. This valuation allowance was based in large part on the Company’s history of generating operating income or losses in individual tax locales and expectations for the future. The Company’s ability to generate the expected amounts of taxable income from future operations to realize its recorded net deferred tax assets is dependent upon general economic conditions, competitive pressures on revenues and margins and legislation and regulation at all levels of government. There can be no assurances that the Company will meet its expectations of future taxable income. However, management has considered the above factors in reaching its conclusion that it is more likely than not that future taxable income will be sufficient to realize the deferred tax assets (net of valuation allowance) as of December 31, 2014.

	During 2014, the valuation allowance increased by $0.2 million due to a change in expected realizability of deferred tax assets.

	The principal tax carry-forwards and temporary differences were as follows as of December 31:

		2014			2013
	Deferred tax assets
	Non-deductible reserves and allowances	$	9,853		$	10,760
	Insurance accruals	3,174			2,408
	Net operating loss carryforwards	1,484			1,160
		14,511			14,328
	Valuation allowance	(1,746		)	(1,521		)
	Deferred tax assets	12,765			12,807

	Deferred tax liabilities
	Goodwill & intangibles	(23,038		)	(17,093		)
	Accelerated depreciation	(1,007		)	(1,494		)
	Deferred tax liabilities	(24,045		)	(18,587		)
	Net deferred tax liabilities	$	(11,280	)	$	(5,780	)

	Deferred tax (liabilities) assets are reflected in the accompanying balance sheet as:
	Current assets	12,230			12,224
	Long-term liabilities	(23,510		)	(18,004		)
	Net deferred tax liabilities	$	(11,280	)	$	(5,780	)

	The Company had book goodwill of $108.7 million and $109.0 million at December 31, 2014 and 2013, respectively, which was not deductible for tax purposes.

	State operating loss carryforwards totaling $29.8 million at December 31, 2014 are being carried forward in jurisdictions where the Company is permitted to use tax losses from prior periods to reduce future taxable income. If not used to offset future taxable income, these losses will expire between 2015 and 2034. Due to uncertainty regarding the Company’s ability to use some of the carryforwards, a valuation allowance has been established on $25.9 million of state net operating loss carryforwards. Based on the Company’s historical record of producing taxable income and expectations for the future, the Company has concluded that future operating income will be sufficient to give rise to taxable income sufficient to utilize the remaining state net operating loss carryforwards.

	US GAAP prescribes a recognition threshold and measurement attribute for the accounting and financial statement disclosure of tax positions taken or expected to be taken in a tax return. The evaluation of a tax position is a two-step process. The first step requires the Company to determine whether it is more likely than not that a tax position will be sustained upon examination based on the technical merits of the position. The second step requires the Company to recognize in the financial statements each tax position that meets the more likely than not criteria, measured at the amount of benefit that has a greater than 50% likelihood of being realized. The Company’s unrecognized tax benefits would affect the tax rate, if recognized. The Company includes the full amount of unrecognized tax benefits in other noncurrent liabilities in the consolidated balance sheets. The Company anticipates it is reasonably possible an increase or decrease in the amount of unrecognized tax benefits could be made in the next twelve months. However, the Company does not presently anticipate that any increase or decrease in unrecognized tax benefits will be material to the consolidated financial statements. During the year ended December 31, 2014, changes in unrecognized tax benefits were as follows.

	Balance at December 31, 2013	$	—
	Increases related to positions taken on items from prior years	—
	Decreases related to positions taken on items from prior years	—
	Increases related to positions taken in the current year	1,186
	Lapse of statute of limitations	—
	Settlement of uncertain tax positions with tax authorities	—
	Balance at December 31, 2014	$	1,186

	For federal tax purposes, the Company is currently subject to examinations for tax years after 2010, while for state purposes, tax years after 2007 are subject to examination, depending on the specific state rules and regulations. The Internal Revenue Service completed an examination of the December 31, 2011 tax year and is currently conducting an examination of Omni Home Health Holdings, Inc.’s federal tax returns for the year ended December 31, 2012 and the period ended December 6, 2013.

	The Company may from time to time be assessed interest and penalties by major tax jurisdictions, although any such assessments historically have been minimal and immaterial to its financial results. Assessments for interest and/or penalties are classified in the financial statements as general and administrative - other.

STOCKHOLDERS_EQUITY

STOCKHOLDERS' EQUITY	12 Months Ended
STOCKHOLDERS' EQUITY	Dec. 31, 2014
STOCKHOLDERS' EQUITY
STOCKHOLDERS' EQUITY	NOTE 7 - STOCKHOLDERS’ EQUITY

	Employee Stock Incentive Plans

	The Company has a 2000 Employee Stock Option Plan which initially provided for options to purchase up to 1,000 shares of the Company’s common stock to key employees, officers and directors. The Board of Directors determines the amount and terms of the options, which cannot exceed ten years. At December 31, 2014, options for 103 shares were outstanding under this plan. There are no shares available for future grant.

	Historically, the Company has issued restricted share and/or option awards to employees and non-employee directors. The Board of Directors determines the amount and terms of the options, which cannot exceed ten years. Under both the 2013 and 2007 Stock and Incentive Compensation Plans, restricted share awards cliff vest on the third anniversary, while option share awards vest annually in 25% increments over four years.

	The 2007 Stock and Incentive Compensation Plan provided for stock awards up to 500 shares of the Company’s common stock to employees, non-employee directors or independent contractors, with a maximum number of full value restricted share awards up to 200. As of December 31, 2014, options for 245 shares were outstanding under this plan, while 162 restricted shares had been awarded. There are no shares available for future grant.

	The 2013 Stock and Incentive Compensation Plan provides for stock awards up to 700 shares of the Company’s common stock to employees, non-employee directors or independent contractors, with a maximum number of full value restricted share awards up to 200. As of December 31, 2014, options for 78 shares had been granted and were outstanding under this plan, while 86 restricted shares had been awarded. There are 536 shares available for future grant.

	Changes in award shares outstanding are summarized as follows:

			Restricted shares					Options
			Shares		Wtd. Avg.			Shares		Wtd. Avg.			Aggregate
					Grant Price					Ex. Price			Intrinsic
													Value
	December 31, 2011		71		$	37.85		292		$	25.15		$	1,110
	Granted		29		24.16			63		24.16			302
	Vested or Exercised		(44	)	37.61			(11	)	6.49			(247		)
	Forfeited		(6	)	28.55			(3	)	(20.19		)	(147		)
	December 31, 2012		50		$	31.35		341		$	25.62		1,136
	Granted		58		20.29			68		20.71			560
	Vested or Exercised		(8	)	19.57			(2	)	12.29			(33		)
	Forfeited		—		—			(24	)	(30.29		)	(1,422		)
	December 31, 2013		100		$	24.12		383		$	24.52		1,697
	Granted		61		23.27			70		24.28			327
	Vested or Exercised		(39	)	27.35			(13	)	2.87			(339		)
	Forfeited		—		—			(13	)	(24.57		)	(696		)
	December 31, 2014		122		$	22.68		427		$	24.89		1,734

	Aggregate intrinsic value represents the estimated value of the Company’s common stock at the end of the period in excess of the weighted average exercise price multiplied by the number of options outstanding or exercisable.

	The following table summarizes information about stock options at December 31, 2014:

			Options Outstanding							Options Exercisable
	Range of		Shares		Wtd. Avg.		Wtd. Avg.			Shares		Wtd. Avg.		Wtd. Avg.
	Exercise				Remaining		Exercise					Remaining		Exercise
	Price				Contractual		Price					Contractual		Price
					Life							Life
	$0.00-20.00		116		2.51		$	19.41		106		2.25		$	19.40
	$20.01-30.00		214		7.60		$	22.91		80		5.38		$	22.62
	Over $30.00		97		4.68		$	35.88		87		4.68		$	35.80
			427		5.55		$	24.89		273		3.95		$	25.59

	The following table details exercisable options and related information for the year ended December 31:

			2014			2013			2012
	Exercisable at end of year		273			259			240
	Weighted average price		$	25.59		$	24.89		$	24.33

	Weighted average fair value of options granted during the year		$	11.61		$	9.59		$	10.92

	The following table details unvested options for the year ended December 31, 2014:

			Shares		Wtd. Avg.
			Shares		Ex. Price
	December 31, 2013		124		$	23.77
	Vested		38		25.08
	Granted		70		24.28
	Forfeited		(2	)	(25.75		)
	December 31, 2014		154		$	23.65

The fair value of each option award is estimated on the date of grant using the Monte Carlo option valuation model with suboptimal exercise behavior. The Monte Carlo model places greater emphasis on market evidence and predicts more realistic results because it considers open form information including volatility, employee exercise behaviors and turnover. Stock options have a contractual term of 10 years. The following assumptions were used in determining the fair value of option awards for 2014:

Grant date		Equivalent		Equivalent		Implied
Grant date		interest rate		volatility		expected lives
March 17, 2014		2.68	%	40.00	%	8.32

Expected volatility is based on an analysis that looks at the unbiased standard deviation of the Company’s common stock over the option term as well as implied volatilities of all long-term exchange traded options for the Company. The expected life of the options represents the period of time that the Company expects the options granted to be outstanding. The risk-free rate is based on the U.S. Treasury yield curve in effect at the time of the grant of the option for the expected term of the instrument. A 0% dividend yield was assumed as no dividend payout over the term of the award is expected.

As of December 31, 2014, there was $2,238 of total unrecognized compensation cost, after estimated forfeitures, related to unvested share-based compensation granted under the plans. That cost is expected to be recognized over a weighted-average period of 2.48 years. The total fair value of option shares vested during the 2014 and 2013 was $370 and $375, respectively.

Employee Stock Purchase Plan

The Company has an Employee Stock Purchase Plan (“2009 ESPP”) which, if implemented, could provide employees of the Company and its subsidiaries with an opportunity to participate in the growth of the Company and to further align the interest of the employees with the interests of the Company through the purchase of shares of the Company’s Common Stock. Under the 2009 ESPP, 300 shares of the Company’s Common Stock have been authorized for issuance. As of December 31, 2014, all 300 shares remain available for issuance.

Directors Deferred Compensation Plan

The Company had a Non-Employee Directors Deferred Compensation Plan (the “Deferred Plan”) which allowed Directors to elect to receive fees for Board services in the form of shares of the Company’s common stock. Directors’ fees were expensed as incurred whether paid in cash or deferred into the Deferred Plan. The Deferred Plan was terminated as of February 22, 2010 with all shares distributed on February 23, 2011. During 2012, the Company redeemed 72 shares of stock for $1.7 million related to this distribution.

RETIREMENT_PLAN

RETIREMENT PLAN	12 Months Ended
RETIREMENT PLAN	Dec. 31, 2014
RETIREMENT PLAN
RETIREMENT PLAN	NOTE 8 - RETIREMENT PLAN

	The Company administers a 401(k) defined contribution retirement plan for the benefit of the majority of its employees. Employees may participate in the plan immediately upon employment. The Company matches contributions in an amount equal to one-quarter of the first 5% of each participant’s contribution to the plan after completion of one year of service with the Company. 401(k) assets are held by an independent trustee, are not assets of the Company, and accordingly are not reflected in the Company’s balance sheets. The Company’s retirement plan expense was approximately $910, $550 and $509 for the years ended December 31, 2014, 2013, and 2012, respectively.

COMMITMENTS_AND_CONTINGGENCIES

COMMITMENTS AND CONTINGGENCIES	12 Months Ended
	Dec. 31, 2014
COMMITMENTS AND CONTINGENCIES
COMMITMENTS AND CONTINGENCIES	NOTE 9 - COMMITMENTS AND CONTINGENCIES

	Operating Leases

	The Company leases certain real estate, office space, and equipment under non-cancelable operating leases expiring at various dates through 2019 and which contain various renewal and escalation clauses. Rent expense amounted to approximately $12,846, $8,619 and $8,656 for years ended December 31, 2014, 2013 and 2012, respectively. At December 31, 2014, minimum rental payments under these leases were as follows:

	2015	$	6,841
	2016	4,230
	2017	2,464
	2018	1,080
	2019	304
	Thereafter	18
	Total	$	14,937

	Legal Proceedings

	The Company is currently, and from time to time, subject to claims and suits arising in the ordinary course of its business, including claims for damages for personal injuries. In the opinion of management, after discussions with legal counsel, the ultimate resolution of any of these ordinary course pending claims and legal proceedings will not have a material effect on the Company’s financial position or results of operations.

SEGMENT_DATA

SEGMENT DATA	12 Months Ended
SEGMENT DATA	Dec. 31, 2014
SEGMENT DATA
SEGMENT DATA	NOTE 10 - SEGMENT DATA

	At December 31, 2014, the Company has two divisions, Home Health Care and Healthcare Innovations. The Home Health Care division is comprised of two reportable segments, Visiting Nurses Services (VN or Visiting Nurse) and Personal Care Services (PC or Personal Care). Healthcare Innovations is also a reportable segment. The Company has updated its business segment reporting at December 31, 2014, in light of changes in how management has organized the business by services provided to customers and the resulting changes in how the chief operating decision maker manages the business and allocates resources, consistent with the criteria in ASC 280, Segment Reporting. Under the new segment structure, the Company has moved the results of Imperium, an acquisition the Company completed in 2013, from Unallocated into a new reportable segment, Healthcare Innovations. The Company has also moved its behavioral health business from the VN segment to the PC segment. Within PC, patient length of stays are much longer, often exceeding a year, which better aligns the types of services offered to behavioral health customers.

	Consistent with information given to the chief operating decision maker, the Company does not allocate certain corporate expenses to the reportable segments. These expenses are included in Unallocated below. The Company evaluates the performance of its business segments based on operating income. Intercompany and intersegment transactions have been eliminated. Segment information within the consolidated financial statements have been recast for all periods presented to conform with the new segment reporting structure.

	The Company’s VN segment provides skilled medical services in patients’ homes largely to enable recipients to reduce or avoid periods of hospitalization and/or nursing home care. VN Medicare revenues are generated on a per episode basis rather than a fee per visit or day of care. Approximately 94% of the VN segment revenues are generated from the Medicare program, while the balance is generated from Medicaid and private insurance programs.

	The Company’s PC segment services are also provided in patients’ homes. These services (generally provided by paraprofessional staff such as home health aides) are generally of a custodial rather than skilled nature. PC revenues are generated on an hourly basis. Approximately 79% of the PC segment revenues are generated from Medicaid and other government programs, while the balance is generated from insurance programs and private pay patients.

	The Company’s Healthcare Innovations business segment was created to house and separately report on our developmental activities outside the traditional home health business platform. These activities are intended ultimately, whether directly or indirectly, to benefit the Company’s patients and payers through the enhanced provision of home health services. The activities all share a common goal of improving patient experiences and quality outcomes while lowering costs. They include, but are not limited to, items such as: technology, information, population health management, risk-sharing, care coordination and transitions, clinical advancements, enhanced patient engagement and informed clinical decision.


		Year Ended December 31,
		2014			2013			2012
	Net service revenues
	Home Health
	Visiting Nurse	$	380,788		$	263,789		$	251,645
	Personal Care	112,497			92,927			88,975
	Healthcare Innovations	2,544			196			—
		$	495,829		$	356,912		$	340,620
	Operating income
	Home Health
	Visiting Nurse	$	46,224		$	29,533		$	37,104
	Personal Care	12,968			11,599			11,758
	Healthcare Innovations	(13		)	(482		)	—
	Unallocated	(34,537		)	(25,857		)	(20,909		)
		$	24,642		$	14,793		$	27,953
	Identifiable assets
	Home Health
	Visiting Nurse	$	259,521		$	257,315
	Personal Care	67,238			56,885
	Healthcare Innovations	9,287			9,642
	Unallocated	21,442			24,942
		$	357,488		$	348,784
	Identifiable liabilities
	Home Health
	Visiting Nurse	$	28,180		$	34,973
	Personal Care	19,498			5,520
	Healthcare Innovations	180			645
	Unallocated	76,438			89,936
		$	124,296		$	131,074
	Noncontrolling Interest - Redeemable
	Healthcare Innovations	$	3,639		$	3,639

	Capital expenditures
	Home Health
	Visiting Nurse	$	465		$	764		$	680
	Personal Care	149			267			648
	Unallocated	618			1,471			1,099
		$	1,232		$	2,502		$	2,427
	Depreciation and amortization
	Home Health
	Visiting Nurse	$	1,250		$	1,004		$	1,004
	Personal Care	271			224			156
	Unallocated	2,582			1,634			1,392
		$	4,103		$	2,862		$	2,552

DISCONTINUED_OPERATIONS

DISCONTINUED OPERATIONS	12 Months Ended
DISCONTINUED OPERATIONS	Dec. 31, 2014
DISCONTINUED OPERATIONS.
DISCONTINUED OPERATIONS	NOTE 11 — DISCONTINUED OPERATIONS

	The Company follows the guidance in Accounting Standards Codification (ASC) 205-20, Discontinued Operations and, when appropriate, reclassifies operating units closed, sold or held for sale out of continuing operations and into discontinued operations for all periods presented. In the first quarter of 2014, the Company’s VN segment exited a market in the Northeast through the closure of a branch location. In conjunction with the SunCrest acquisition in 2013, the Company acquired some operations which had been discontinued prior to acquisition. In 2013, the Company completed the sale of two Alabama locations, which operated in the VN segment. The operations and gain on sale related to the Alabama operations were reclassified from continuing operations into discontinued operations for all periods presented. The operations and any related gain on sale for these operations were reclassified from continuing operations into discontinued operations for all periods presented. The effective tax rate for discontinued operations is high in 2013 due primarily to the impact of writing off non-deductible goodwill in addition to providing a valuation allowance for Alabama net operating loss carryforwards. Unless otherwise noted, amounts in these Notes to Consolidated Financial Statements exclude amounts attributable to discontinued operations.

ACQUISITIONS

ACQUISITIONS	12 Months Ended
	Dec. 31, 2014
ACQUISITIONS
ACQUISITIONS	NOTE 12 - ACQUISITIONS

	The Company completed each of the following acquisitions in pursuit of its strategy for operational expansion in the eastern United States through an expanded service base and enhanced position in certain geographic areas. The purchase price of each acquisition was determined based on the Company’s analysis of comparable acquisitions, expected cash flows and arm’s length negotiation with the sellers. Each acquisition was included in the Company’s consolidated financial statements from the respective acquisition date.

	Goodwill recognized from the acquisitions primarily relates to expected contributions of each entity to the overall corporate strategy in addition to synergies and acquired workforce, which are not separable from goodwill. Goodwill and other intangible assets generated in asset purchase transactions are expected to be amortizable for tax purposes on a straight-line basis over 15 years, unless otherwise noted. Goodwill and other intangible assets generated in stock purchase transactions are not amortizable, unless otherwise noted. The purchase price allocations for 2013 acquisitions are final.

	During 2014, we completed a small acquisition using cash on hand to expand existing VN segment operations.

	On December 6, 2013, the Company acquired the stock of SunCrest. SunCrest and its subsidiaries owned and operated 66 Medicare-certified home health agencies and 9 private duty agencies in Florida, Tennessee, Georgia, Pennsylvania, Kentucky, Illinois, Indiana, Mississippi and Alabama. The total SunCrest purchase price for the stock was $76.6 million, subject to a working capital adjustment. The purchase price consisted of cash consideration of $75.1 million and a $1.5 million note payable, net of acquired cash balances of $2.2 million. The following table summarizes the estimated fair values of the assets acquired and liabilities assumed of the SunCrest acquisition.

		Final Purchase			Preliminary			Change
		Price Allocation			Purchase Price
					Allocation
	Accounts Receivable	$	11,330		$	16,237		$	(4,907	)
	Property, plant & equipment	2,254			2,276			(22		)
	Other assets	2,497			2,933			(436		)
	Deferred tax assets	5,720			—			5,720
	Goodwill	43,748			44,096			(348		)
	Other intangibles	31,750			33,390			(1,640		)
	Assets acquired	97,299			98,932			(1,633		)
	Liabilities assumed	(20,742		)	(22,375		)	1,633
	Net assets acquired	$	76,557		$	76,557		$	—

	Amortizable goodwill and intangibles acquired in the SunCrest acquisition are expected to provide an annual tax deduction approximating $4.3 million through 2025.

	On October 4, 2013, the Company acquired 61.5% of Imperium for $5.8 million, of which $3.0 million was working capital for Imperium. Imperium is a development-stage enterprise that provides strategic health management services to ACOs. Substantially all of the purchase price was allocated to goodwill. The Company is party to a put and call arrangement with respect to the remaining 38.5% non-controlling interest in Imperium. The redemption value for both the put and the call arrangement is equal to fair value. Due to the existing put and call arrangements, the non-controlling interest is considered to be redeemable and is recorded on the balance sheet as a redeemable non-controlling interest outside of permanent equity. The redeemable non-controlling interest is recognized at the higher of 1) the accumulated earnings associated with the non-controlling interest or 2) the redemption value as of the balance sheet date.

	On July 17, 2013, the Company acquired the assets of the Medicare-certified home agencies owned by IHCN. IHCN operated six home health agencies primarily in northern Indiana for a total purchase price of $12.5 million consisting of cash and $0.5 million of Almost Family, Inc. common stock. A preliminary allocation of purchase price resulted primarily in the allocation of $9.9 million to goodwill, $1.8 million to identified intangibles with the remainder primarily due to property plant and equipment and accounts receivable.

	During 2012, the Company completed two small acquisitions to expand existing VN and PC segment operations.

QUARTERLY_FINANCIAL_DATA_UNAUD

QUARTERLY FINANCIAL DATA - (UNAUDITED)	12 Months Ended
	Dec. 31, 2014
QUARTERLY FINANCIAL DATA - (UNAUDITED)
QUARTERLY FINANCIAL DATA - (UNAUDITED)	NOTE 13 - QUARTERLY FINANCIAL DATA— (UNAUDITED)

	Summarized quarterly financial data are as follows for the years ended December 31:

		2014											2013
		Dec. 31		Sept. 30			Jun. 30			Mar. 31			Dec. 31			Sept. 30			Jun. 30			Mar. 31
	Net service revenues	$	124,756	$	125,540		$	125,193		$	120,340		$	96,588		$	88,471		$	86,400		$	85,453
	Gross margin	58,366		59,019			59,636			54,813			45,006			41,096			40,254			40,008
	Income from continuing operations attributable to Almost Family, Inc.	4,747		3,820			4,025			1,343			578			2,315			2,581			3,310
	Discontinued operations	1		(39		)	(64		)	(70		)	(250		)	(186		)	(59		)	(63		)
	Net income attributable to Almost Family, Inc.	$	4,748	$	3,781		$	3,961		$	1,273		$	328		$	2,129		$	2,522		$	3,247

	Average shares outstanding
	Basic	9,352		9,347			9,338			9,293			9,308			9,302			9,270			9,254
	Diluted	9,474		9,443			9,431			9,426			9,401			9,348			9,348			9,338

	Net income attributable to Almost Family, Inc. per share
	Basic	$	0.5	$	0.4		$	0.42		$	0.14		$	0.03		$	0.23		$	0.27		$	0.35
	Diluted	$	0.49	$	0.4		$	0.42		$	0.14		$	0.02		$	0.23		$	0.27		$	0.35

SUBSEQUENT_EVENTS

SUBSEQUENT EVENTS	12 Months Ended
SUBSEQUENT EVENTS	Dec. 31, 2014
SUBSEQUENT EVENTS
SUBSEQUENT EVENTS	NOTE 14 - SUBSEQUENT EVENTS

	Management has evaluated all events and transactions that occurred after December 31, 2014. The following non-recognized subsequent events were noted:

	On February 24, 2015 the Company signed a definitive agreement to acquire the stock of WillCare. WillCare, based in Buffalo NY, reported $72 million in revenue in 2014 with VN and PC branch locations in New York (11), Connecticut (3) and Ohio (1). The purchase price is expected to be between $46 and $53 million based on changes in earnings and working capital between execution of the definitive agreement and the expected close sometime in the second half of FY2015 subject to New York approval. The transaction will be funded by borrowings under the Company’s bank credit facility.

	On January 29, 2015, the Company entered into an agreement to invest up to $2 million for a noncontrolling interest in a development stage data analytics software company, NavHealth, Inc. The cost basis investment is an asset of our Health Innovations segment.

SCHEDULE_II_VALUATION_AND_QUAL

SCHEDULE II - VALUATION AND QUALIFYING ACCOUNTS	12 Months Ended
	Dec. 31, 2014
SCHEDULE II - VALUATION AND QUALIFYING ACCOUNTS
SCHEDULE II - VALUATION AND QUALIFYING ACCOUNTS	ALMOST FAMILY, INC. AND SUBSIDIARIES
	VALUATION AND QUALIFYING ACCOUNTS
	SCHEDULE II
	(In thousands)
			Col. A		Col. B		Col. C		Col. D			Col. E
					Additions/(Deductions)
	Description		Balance at		-1		-2		-3			Balance at
			Beginning		Charged to		Charged to		Deductions			End of
			of Period		Costs and		Other					Period
					Expenses		Accounts

	Allowances:
	Year Ended December 31, 2013		$	15,586	$	9,413	$	—	$	(16,119	)	$	8,880

	Year Ended December 31, 2013		$	5,236	$	5,526	$	8,910	$	(4,086	)	$	15,586

	Year Ended December 31, 2012		$	6,664	$	2,825	$	46	$	(4,299	)	$	5,236

		-1		Charged to bad debt expense.
		-2		Acquired uncollectible accounts reserves, primarily SunCrest acquisition related.
		-3		Write-off of accounts.

SUMMARY_OF_SIGNIFICANT_ACCOUNT1

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)	12 Months Ended
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)	Dec. 31, 2014
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
Basis of Consolidation and Description Of Business
	Basis of Consolidation and Description Of Business

	The consolidated financial statements include the accounts of Almost Family, Inc. (a Delaware corporation) and its wholly-owned subsidiaries (collectively “Almost Family” or the “Company”). The Company is a leading, regionally focused provider of home health services and has service locations in Florida, Tennessee, Ohio, Kentucky, Connecticut, New Jersey, Massachusetts, Indiana, Illinois, Pennsylvania, Georgia, Missouri, Mississippi and Alabama (in order of revenue significance).

	The Company was incorporated in Delaware in 1985. Through a predecessor that merged into the Company in 1991, the Company has been providing health care services, primarily home health care, since 1976. All material intercompany transactions and accounts have been eliminated in consolidation.

	On December 6, 2013, the Company completed the acquisition of Omni Home Health Holdings, Inc. (“SunCrest”). Branded principally under the SunCrest name, its subsidiaries owned and operated 66 Medicare-certified home health agencies and 9 private duty agencies in Florida, Tennessee, Georgia, Pennsylvania, Kentucky, Illinois, Indiana, Mississippi and Alabama. On October 4, 2013, the Company acquired a controlling interest in Imperium Health Management, LLC (“Imperium”), a development-stage enterprise that provides strategic health management services to Accountable Care Organizations (“ACO’s”). On July 17, 2013, the Company acquired the assets of the Medicare-certified home health agencies owned by Indiana Home Care Network (“IHCN”). The acquisitions are more fully described in Note 12, “Acquisitions”. The results of operations for SunCrest and IHCN are principally reported within the Company’s Visiting Nurse reportable segment, while Imperium results are currently included the Company’s Healthcare Innovations segment. The Company’s consolidated financial statements are prepared in accordance with U.S. generally accepted accounting principles (US GAAP). All intercompany balances and transactions have been eliminated.

New Accounting Pronouncements	New Accounting Pronouncements

	The Financial Accounting Standards Board issued Accounting Standards Update No. 2014-09, Revenue from Contracts with Customers (Topic 606), during the second quarter of 2014. Topic 606 affects virtually all aspects of an entity’s revenue recognition, including determining the measurement of revenue and the timing of when it is recognized for the transfer of goods or services to customers. Topic 606 is effective for annual reporting periods beginning after December 15, 2016. The Company is currently evaluating the effect of the adoption of Topic 606 on its financial position and results of operations.

Cash and Cash Equivalents	Cash and Cash Equivalents

	The Company considers all highly liquid debt instruments purchased with an original maturity of three months or less to be cash equivalents.

	Uninsured deposits at December 31, 2014 and 2013 were approximately $4,183 and $9,449, respectively. These amounts have been deposited with national financial institutions.

Property and Equipment	Property and Equipment

	Property and equipment are stated at cost. Depreciation is computed using the straight-line method over the estimated useful lives (generally two to ten years for medical and office equipment and three years for internally developed software). Leasehold improvements are depreciated over the terms of the respective leases (generally three to ten years). Such costs are periodically reviewed for recoverability when impairment indicators are present. Such indicators include, among other factors, operating losses, unused capacity, market value declines and technological obsolescence. Recorded values of asset groups of property, plant and equipment that are not expected to be recovered through undiscounted future net cash flows are written down to current fair value, which generally is determined from estimated discounted future net cash flows (assets held for use) or net realizable value (assets held for sale).

Goodwill and Other Intangible Assets
	Goodwill and Other Intangible Assets

	Goodwill and indefinite lived intangible assets acquired are stated at fair value at the date of acquisition. Subsequent to acquisition, the Company conducts annual reviews for impairment, or more frequently if circumstances indicate impairment may have occurred. The Company reviews goodwill for impairment based on its identified reporting units, which are the same as its reportable segments. The Company tests goodwill for impairment by comparing the carrying value to the estimated fair value of its reporting units, determined using a combination of the market approach (guideline company and similar transaction method) and income approach (discounted cash flow analysis). The Company annually tests its indefinite-lived intangible assets, principally trade names, certificates of need, provider numbers and licenses. Specifically trade names are tested using a “relief-from-royalty” valuation method compared to the carrying value. Significant assumptions inherent in the valuation methodologies for goodwill and other intangibles are employed and include, but are not limited to, such estimates as future projected business results, growth rates, legislated changes in payment rates, weighted-average cost of capital for a market participant, royalty and discount rates. The Company has completed its most recent annual impairment tests as of December 31, 2014 and determined that no impairment existed.

	Finite-lived intangible assets are amortized on a straight-line basis over their estimated useful lives, such as the cost of non-compete agreements for which their estimated useful life is usually 3 years, beginning after the earn-out period, if any.

	The following table summarizes the activity related to the Company’s goodwill and other intangible assets:

					Other Intangible Assets
		Goodwill			Certificates			Trade			Non-compete			Total
					of Need and			Names			Agreements
					Licenses
	December 31, 2012 balance	$	133,471		$	9,391		$	10,421		$	155		$	19,967
	Acquisitions	60,475			28,930			4,370			—			33,300
	Disposals	(1,457		)	—			—			—			—
	Amortization	—			—			(10		)	(83		)	(93		)
	December 31, 2013 balance	$	192,489		$	38,321		$	14,781		$	72		$	53,174
	Acquisitions	—			1,290			—			—			1,290
	Changes	34			—			—			—			—
	Amortization	—			—			(10		)	(52		)	(62		)
	December 31, 2014 balance	$	192,523		$	39,611		$	14,771		$	20		$	54,402

	Additions were due to acquisitions (Note 12) and disposals were due to asset dispositions (Note 11).

	The following table summarizes the Company’s goodwill and other intangible assets by segment:

					Other Intangible Assets
		Goodwill			Certificates			Trade			Non-compete			Total
					of Need and			Names			Agreements
					Licenses
	Visiting Nurse	$	147,368		$	37,541		$	11,401		$	23		$	48,965
	Personal Care	37,571			780			3,380			49			4,209
	Healthcare Innovations	7,550			—			—			—			—
	December 31, 2013 balance	$	192,489		$	38,321		$	14,781		$	72		$	53,174

	Visiting Nurse	$	147,368		$	38,831		$	11,391		$	10		$	50,232
	Personal Care	37,571			780			3,380			10			4,170
	Healthcare Innovations	7,584			—			—			—			—
	December 31, 2014 balance	$	192,523		$	39,611		$	14,771		$	20		$	54,402


Capitalization Policies	Capitalization Policies

	Maintenance, repairs and minor replacements are charged to expense as incurred. Major renovations and replacements are capitalized to appropriate property and equipment accounts. Upon sale or retirement of property, the cost and related accumulated depreciation are eliminated from the accounts and the related gain or loss is recognized in the consolidated statement of income.

	The Company capitalizes the cost of internally developed computer software for the Company’s own use. Software development costs of approximately $327, $647 and $968 were capitalized in the years ended December 31, 2014, 2013 and 2012, respectively.

Insurance Programs	Insurance Programs

	The Company bears significant risk under its large-deductible workers’ compensation insurance program and its self-insured employee health program. Under the workers’ compensation insurance program, the Company bears risk up to $250 per incident, after which stop-loss coverage is maintained. The Company purchases stop-loss insurance for the employee health plan that places a specific limit, generally $300, on its exposure for any individual covered life.

	Malpractice and general patient liability claims for incidents which may give rise to litigation have been asserted against the Company by various claimants. The claims are in various stages of processing and some may ultimately be brought to trial. The Company currently carries professional and general liability insurance coverage (on a claims made basis) for this exposure with no deductible. The Company also carries D&O coverage (also on a claims made basis) for potential claims against the Company’s directors and officers, including securities actions, with deductibles ranging from $100 to $200 per claim.

	The Company records estimated liabilities for its insurance programs based on information provided by the third-party plan administrators, historical claims experience, the life cycle of claims, expected costs of claims incurred but not paid, and expected costs to settle unpaid claims. The Company monitors its estimated insurance-related liabilities and recoveries, if any, on a monthly basis and as required by ASU No. 2010-24, Health Care Entities (Topic 954): Presentation of Insurance Claims and Related Insurance Recoveries, records amounts due under insurance policies in other current assets, while recording the estimated carrier liability in other current liabilities. As facts change, it may become necessary to make adjustments that could be material to the Company’s results of operations and financial condition.

Accounting for Income Taxes	Accounting for Income Taxes

	The Company recognizes deferred tax assets and liabilities for the expected future tax consequences of events that have been included in the financial statements or tax returns. Under this method, deferred tax assets and liabilities are determined based on the difference between the Company’s book and tax bases of assets and liabilities and tax carry-forwards using enacted tax rates in effect for the year in which the differences are expected to reverse. The effect of changes in tax rates on deferred taxes is recognized in the period in which the enactment dates change. Valuation allowances are established when necessary on a jurisdictional basis to reduce deferred tax assets to the amounts expected to be realized.

Seasonality	Seasonality

	The Company’s VN segment operations located in Florida (which generated approximately 36% of that segment’s revenues in 2014) normally experience higher admissions during the first quarter and lower admissions during the third quarter than in the other quarters due to seasonal population fluctuations.

Net Service Revenues	Net Service Revenues

	The Company is paid for its services primarily by federal and state third-party reimbursement programs, commercial insurance companies, and patients. Revenues are recorded at established rates in the period during which the services are rendered. Appropriate allowances to give recognition to third party payment arrangements are recorded when the services are rendered.

	Approximately 72% of the Company’s consolidated net service revenues are derived from the Medicare program. Net service revenues are recorded under the Medicare prospective payment program (PPS) based on a 60-day episode payment rate that is subject to adjustment based on certain variables including, but not limited to: (a) changes in the base episode payments established by the Medicare program; (b) adjustments to the base episode payments for case-mix and geographic wages; (c) a low utilization payment adjustment (LUPA) if the number of visits was fewer than five; (d) a partial payment if a patient is transferred to another provider or if a patient is received from another provider before completing the episode; (e) a payment adjustment based upon the level of therapy services required (thresholds set at 6, 14 and 20 visits); (f) an outlier payment if the patient’s care was unusually costly (capped at 10% of total reimbursement); (g) the number of episodes of care provided to a patient; and (h) a 2% reduction for sequestration.

	At the beginning of each Medicare episode the Company calculates an estimate of the amount of expected reimbursement based on the variables outlined above and recognizes Medicare revenue on an episode-by-episode basis during the course of each episode over its expected number of visits. Over the course of each episode, as changes in the variables become known, adjustments are calculated and recorded as needed to reflect changes in expectations for that episode from those established at the start of the 60 day period until its ultimate outcome at the end of the 60 day period is known.

	Substantially all remaining revenues are earned on a per visit, hour or unit basis (as opposed to episodic). For all services provided, the Company uses either payor-specific or patient-specific fee schedules for the recording of revenues at the amounts actually expected to be received.

	Laws and regulations governing the Medicare and Medicaid programs are extremely complex and subject to interpretation. It is common for issues to arise related to: 1) medical coding, particularly with respect to Medicare, 2) patient eligibility, particularly related to Medicaid, and 3) other reasons unrelated to credit risk, all of which may result in adjustments to recorded revenue amounts. The Company continuously evaluates the potential for revenue adjustments and when appropriate provides allowances for losses based upon the best available information. There is at least a reasonable possibility that recorded estimates could change by material amounts in the near term. Changes in estimates related to prior periods (increased) decreased revenues by approximately ($320), $114, and $75 in the years ended December 31, 2014, 2013 and 2012, respectively.

Revenue and Receivable Concentrations
	Revenue and Receivable Concentrations

	The following table sets forth the percent of the Company’s revenues generated from Medicare, state Medicaid programs and other payors for the year ended December 31:

		2014		2013		2012
	Medicare	72.4	%	71.2	%	71.7	%
	Medicaid & other government programs:
	Ohio	8.8	%	11.7	%	11.9	%
	Connecticut	5.5	%	7.1	%	6.6	%
	Tennessee	2.5	%	0.2	%	0.0	%
	Kentucky	1.8	%	2.3	%	2.7	%
	Florida	0.6	%	0.7	%	0.5	%
	Others	0.4	%	0.5	%	0.3	%
	Subtotal	19.6	%	22.5	%	22.0	%
	All other payors	8.0	%	6.3	%	6.3	%
	Total	100.0	%	100.0	%	100.0	%

	Concentrations in the Company’s accounts receivable were as follows as of December 31:

		2014					2013
		Amount			Percent		Amount			Percent
	Medicare	$	46,634		55.7	%	$	42,823		56.7	%
	Medicaid & other government programs:
	Ohio	9,239			11	%	5,925			7.8	%
	Connecticut	3,982			4.8	%	4,884			6.5	%
	Kentucky	3,686			4.4	%	2,536			3.4	%
	Tennessee	5,617			6.7	%	4,099			5.4	%
	Others	2,835			3.4	%	1,968			2.6	%
	Subtotal	25,359			30.3	%	19,412			25.7	%
	All other payors	11,781			14.1	%	13,253			17.6	%
	Subtotal	83,774			100	%	75,488			100	%
	Allowances	(8,880		)			(15,586		)
	Total	$	74,894				$	59,902

	The ability of payors to meet their obligations depends upon their financial stability, future legislation and regulatory actions. The Company does not believe there are any significant credit risks associated with receivables from Federal and state third-party reimbursement programs. The allowance for uncollectible accounts principally consists of management’s estimate of amounts that may prove uncollectible for coverage, eligibility and technical reasons.

Payor Mix Concentrations and Related Aging of Accounts Receivable	Payor Mix Concentrations and Related Aging of Accounts Receivable

	The approximate breakdown by payor classification as a percent of total accounts receivable, net of contractual allowances, if any, at December 31, 2014 and 2013 is set forth in the following tables:

		2014
	Payor	0-90		91-180		181-365		>1 yr.		Total
	Medicare	36	%	13	%	9	%	0	%	58	%
	Medicaid & Government	19	%	6	%	3	%	1	%	29	%
	Self Pay	1	%	0	%	1	%	0	%	2	%
	Insurance	6	%	3	%	2	%	0	%	11	%
	Total	62	%	22	%	15	%	1	%	100	%

		2013
	Payor	0-90		91-180		181-365		>1 yr.		Total
	Medicare	30	%	12	%	5	%	3	%	50	%
	Medicaid & Government	18	%	4	%	4	%	7	%	33	%
	Self Pay	4	%	1	%	1	%	1	%	7	%
	Insurance	4	%	1	%	2	%	3	%	10	%
	Total	56	%	18	%	12	%	14	%	100	%

	Variations between years are largely attributable to the SunCrest acquisition.

Allowance for Uncollectible Accounts by Payor Mix and Related Aging	Allowance for Uncollectible Accounts by Payor Mix and Related Aging

	The Company records an estimated allowance for uncollectible accounts by applying estimated bad debt percentages to its accounts receivable aging. The percentages to be applied by payor type are based on the Company’s historical collection and loss experience. The Company’s effective allowances for uncollectible accounts as a percent of accounts receivable were as follows at December 31, 2014 and 2013:

		2014
	Payor	0-90		91-180		181-365		>1 yr.		>2 yrs.
	Medicare	0	%	0	%	8	%	75	%	100	%
	Medicaid & Government	1	%	8	%	31	%	66	%	100	%
	Self Pay	1	%	12	%	51	%	74	%	100	%
	Insurance	5	%	22	%	46	%	83	%	100	%
	Total	1	%	6	%	23	%	74	%	100	%

		2013
	Payor	0-90		91-180		181-365		>1 yr.		>2 yrs.
	Medicare	0	%	1	%	9	%	100	%	100	%
	Medicaid & Government	2	%	16	%	49	%	92	%	100	%
	Self Pay	5	%	36	%	80	%	87	%	100	%
	Insurance	5	%	22	%	38	%	87	%	100	%
	Total	1	%	8	%	33	%	92	%	100	%

	Variations between years are largely attributable to the SunCrest acquisition.

	The Company’s allowance for uncollectible accounts at December 31, 2014 and 2013 was approximately $8,880 and $15,586, respectively. The increase is primarily due to the SunCrest acquisition.

Contingent Service Revenues	Contingent Service Revenues

	The Company, through its Imperium acquisition, provides strategic health management services to ACOs that have been approved to participate in the Medicare Shared Savings Program (“MSSP”). While the Company did not have ownership interests in ACO’s at December 31, 2014, it had service agreements with ACOs that provide for sharing of MSSPs received by the ACO, if any.

	ACOs are entities that contract with CMS to serve the Medicare fee-for-service population with the goal of better care for individuals, improved health for populations and lower costs. ACOs share savings with CMS to the extent that the actual costs of serving assigned beneficiaries are below certain trended benchmarks of such beneficiaries and certain quality performance measures are achieved. The MSSP is relatively new and therefore has limited historical experience, which impacts the Company’s ability to accurately accumulate and interpret the data available for calculating an ACOs’ shared savings, if any. MSSP payments are not recognized in revenue until persuasive evidence of an agreement exists, services have been rendered, the payment is fixed and determinable and collectability is insured, which is generally satisfied upon cash receipt. Under such agreements, the Company recognized $1.6 million in MSSP payments for cash received during 2014 related to savings generated for the program period ended December 31, 2013, which is included in the Company’s Healthcare Innovations segment revenues. The Company has yet to recognize MSSP payments, if any, for savings generated through December 31, 2014.

Weighted Average Shares	Weighted Average Shares

	Net income per share is presented as a unit of basic shares outstanding and diluted shares outstanding. Diluted shares outstanding is computed based on the weighted average number of common shares and common equivalent shares outstanding. Common equivalent shares result from dilutive stock options and unvested restricted shares. The following table is a reconciliation of basic to diluted shares used in the earnings per share calculation for the year ended December 31:

		2014		2013		2012
	Basic weighted average outstanding shares	9,333		9,279		9,285
	Dilutive effect of outstanding compensation awards	129		95		39
	Diluted weighted average outstanding shares	9,462		9,374		9,324

	The assumed conversions to common stock of 94, 195, and 218 of the Company’s outstanding stock options were excluded from the diluted EPS computation in 2014, 2013, and 2012, respectively, because these items, on an individual basis, have an anti-dilutive effect on diluted EPS.

Use of Estimates	Use of Estimates

	The preparation of financial statements in conformity with accounting principles generally accepted in the United States requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.

Financial Statement Reclassifications	Financial Statement Reclassifications

	Certain prior period amounts and data have been reclassified in the financial statements and related notes in order to conform to the 2014 presentation. Such reclassifications had no effect on previously reported net income. In connection with the SunCrest acquisition, the consolidated balance sheet at December 31, 2013 has been recast to include retrospective purchase accounting adjustments. These adjustments were retrospectively applied to the December 6, 2013 acquisition date balance sheet. These adjustments pertain to measurement period adjustments during the year ended December 31, 2014, which coincides with the one year anniversary date of the acquisition, based on the valuation of assets acquired and liabilities assumed in the SunCrest acquisition. The effect on the consolidated balance sheet at December 31, 2014 is included in Note 12 to the consolidated financial statements.

Stock-Based Compensation	Stock-Based Compensation

	Stock options and restricted stock are granted under various stock compensation programs to employees and independent directors. The Company accounts for such grants in accordance with ASC Topic 718, Compensation — Stock Compensation and amortizes the fair value of awards, after estimated forfeiture, on a straight-line basis over the requisite service periods.

Accounting for Leases
	Accounting for Leases

	The Company accounts for operating leases using the straight-line rents method, which amortizes contracted total rents due evenly over the lease term.

Advertising Costs	Advertising Costs

	The Company expenses the costs of advertising as incurred. Advertising expense was $306, $326 and $316 for the years ended December 31, 2014, 2013, and 2012, respectively.

SUMMARY_OF_SIGNIFICANT_ACCOUNT2

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)	12 Months Ended
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)	Dec. 31, 2014
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
Summary of the activity and segment-wise information related to goodwill and intangible assets					Other Intangible Assets
		Goodwill			Certificates			Trade			Non-compete			Total
					of Need and			Names			Agreements
					Licenses
	December 31, 2012 balance	$	133,471		$	9,391		$	10,421		$	155		$	19,967
	Acquisitions	60,475			28,930			4,370			—			33,300
	Disposals	(1,457		)	—			—			—			—
	Amortization	—			—			(10		)	(83		)	(93		)
	December 31, 2013 balance	$	192,489		$	38,321		$	14,781		$	72		$	53,174
	Acquisitions	—			1,290			—			—			1,290
	Changes	34			—			—			—			—
	Amortization	—			—			(10		)	(52		)	(62		)
	December 31, 2014 balance	$	192,523		$	39,611		$	14,771		$	20		$	54,402

					Other Intangible Assets
		Goodwill			Certificates			Trade			Non-compete			Total
					of Need and			Names			Agreements
					Licenses
	Visiting Nurse	$	147,368		$	37,541		$	11,401		$	23		$	48,965
	Personal Care	37,571			780			3,380			49			4,209
	Healthcare Innovations	7,550			—			—			—			—
	December 31, 2013 balance	$	192,489		$	38,321		$	14,781		$	72		$	53,174

	Visiting Nurse	$	147,368		$	38,831		$	11,391		$	10		$	50,232
	Personal Care	37,571			780			3,380			10			4,170
	Healthcare Innovations	7,584			—			—			—			—
	December 31, 2014 balance	$	192,523		$	39,611		$	14,771		$	20		$	54,402


Schedule of the Company's revenues generated from Medicare, state Medicaid programs and other payors		2014		2013		2012
	Medicare	72.4	%	71.2	%	71.7	%
	Medicaid & other government programs:
	Ohio	8.8	%	11.7	%	11.9	%
	Connecticut	5.5	%	7.1	%	6.6	%
	Tennessee	2.5	%	0.2	%	0.0	%
	Kentucky	1.8	%	2.3	%	2.7	%
	Florida	0.6	%	0.7	%	0.5	%
	Others	0.4	%	0.5	%	0.3	%
	Subtotal	19.6	%	22.5	%	22.0	%
	All other payors	8.0	%	6.3	%	6.3	%
	Total	100.0	%	100.0	%	100.0	%


Schedule of Concentrations in the Company's accounts receivable		2014					2013
		Amount			Percent		Amount			Percent
	Medicare	$	46,634		55.7	%	$	42,823		56.7	%
	Medicaid & other government programs:
	Ohio	9,239			11	%	5,925			7.8	%
	Connecticut	3,982			4.8	%	4,884			6.5	%
	Kentucky	3,686			4.4	%	2,536			3.4	%
	Tennessee	5,617			6.7	%	4,099			5.4	%
	Others	2,835			3.4	%	1,968			2.6	%
	Subtotal	25,359			30.3	%	19,412			25.7	%
	All other payors	11,781			14.1	%	13,253			17.6	%
	Subtotal	83,774			100	%	75,488			100	%
	Allowances	(8,880		)			(15,586		)
	Total	$	74,894				$	59,902


Schedule of approximate breakdown by payor classification as a percent of total accounts receivable, net of contractual allowances		2014
	Payor	0-90		91-180		181-365		>1 yr.		Total
	Medicare	36	%	13	%	9	%	0	%	58	%
	Medicaid & Government	19	%	6	%	3	%	1	%	29	%
	Self Pay	1	%	0	%	1	%	0	%	2	%
	Insurance	6	%	3	%	2	%	0	%	11	%
	Total	62	%	22	%	15	%	1	%	100	%

		2013
	Payor	0-90		91-180		181-365		>1 yr.		Total
	Medicare	30	%	12	%	5	%	3	%	50	%
	Medicaid & Government	18	%	4	%	4	%	7	%	33	%
	Self Pay	4	%	1	%	1	%	1	%	7	%
	Insurance	4	%	1	%	2	%	3	%	10	%
	Total	56	%	18	%	12	%	14	%	100	%


Schedule of the Company's effective allowances for uncollectible accounts as a percent of accounts receivable		2014
	Payor	0-90		91-180		181-365		>1 yr.		>2 yrs.
	Medicare	0	%	0	%	8	%	75	%	100	%
	Medicaid & Government	1	%	8	%	31	%	66	%	100	%
	Self Pay	1	%	12	%	51	%	74	%	100	%
	Insurance	5	%	22	%	46	%	83	%	100	%
	Total	1	%	6	%	23	%	74	%	100	%

		2013
	Payor	0-90		91-180		181-365		>1 yr.		>2 yrs.
	Medicare	0	%	1	%	9	%	100	%	100	%
	Medicaid & Government	2	%	16	%	49	%	92	%	100	%
	Self Pay	5	%	36	%	80	%	87	%	100	%
	Insurance	5	%	22	%	38	%	87	%	100	%
	Total	1	%	8	%	33	%	92	%	100	%


Schedule of reconciliation of basic to diluted shares used in the earnings per share calculation		2014		2013		2012
	Basic weighted average outstanding shares	9,333		9,279		9,285
	Dilutive effect of outstanding compensation awards	129		95		39
	Diluted weighted average outstanding shares	9,462		9,374		9,324

ACCRUED_LIABILITIES_Tables

ACCRUED LIABILITIES (Tables)	12 Months Ended
	Dec. 31, 2014
ACCRUED LIABILITIES
Schedule of components of accrued liabilities		2014		2013
	Wages and employee benefits	$	20,084	$	20,755
	Insurance accruals	14,217		11,602
	Accrued taxes	563		1,046
	Kentucky Medicaid cost report payable	1,360		3,170
	Accrued professional fees and other	6,102		5,923
		$	42,326	$	42,496

PROPERTY_AND_EQUIPMENT_NET_Tab

PROPERTY AND EQUIPMENT, NET (Tables)	12 Months Ended
	Dec. 31, 2014
PROPERTY AND EQUIPMENT, NET
Schedule of Property and equipment, net		2014			2013
	Leasehold improvements	$	1,367		$	1,448
	Medical equipment	937			1,671
	Computer equipment	9,607			14,594
	Internally developed software	3,807			1,404
	Office and other equipment	4,502			5,071
	Vehicles	449			387
		20,669			24,575
	Less accumulated depreciation	(15,094		)	(16,455		)
		$	5,575		$	8,120

INCOME_TAXES_Tables

INCOME TAXES (Tables)	12 Months Ended
INCOME TAXES (Tables)	Dec. 31, 2014
INCOME TAXES
Schedule of the components of provision for income taxes		2014			2013			2012
	Federal - current	$	2,829		$	3,557		$	6,113
	State and local - current	1,182			364			1,181
	Deferred	5,500			2,099			3,753
		$	9,511		$	6,020		$	11,047


Schedule of reconciliation of the statutory to the effective rate		2014		2013		2012
	Tax provision using statutory rate	35.0	%	35.0	%	35.0	%
	State and local taxes, net of Federal benefit	4.7	%	5.7	%	4.1	%
	Valuation allowance	1.0	%	-0.6	%	-0.6	%
	Noncontrolling interest related	0.4	%	0.5	%	0.0	%
	Other, net	-0.1	%	1.3	%	0.7	%
	Tax provision for continuing operations	41.0	%	41.9	%	39.2	%


Schedule of the principal tax carry-forwards and temporary differences		2014			2013
	Deferred tax assets
	Non-deductible reserves and allowances	$	9,853		$	10,760
	Insurance accruals	3,174			2,408
	Net operating loss carryforwards	1,484			1,160
		14,511			14,328
	Valuation allowance	(1,746		)	(1,521		)
	Deferred tax assets	12,765			12,807

	Deferred tax liabilities
	Goodwill & intangibles	(23,038		)	(17,093		)
	Accelerated depreciation	(1,007		)	(1,494		)
	Deferred tax liabilities	(24,045		)	(18,587		)
	Net deferred tax liabilities	$	(11,280	)	$	(5,780	)

	Deferred tax (liabilities) assets are reflected in the accompanying balance sheet as:
	Current assets	12,230			12,224
	Long-term liabilities	(23,510		)	(18,004		)
	Net deferred tax liabilities	$	(11,280	)	$	(5,780	)


Schedule of changes in unrecognized tax benefits.	Balance at December 31, 2013	$	—
	Increases related to positions taken on items from prior years	—
	Decreases related to positions taken on items from prior years	—
	Increases related to positions taken in the current year	1,186
	Lapse of statute of limitations	—
	Settlement of uncertain tax positions with tax authorities	—
	Balance at December 31, 2014	$	1,186

STOCKHOLDERS_EQUITY_Tables

STOCKHOLDERS' EQUITY (Tables)	12 Months Ended
STOCKHOLDERS' EQUITY (Tables)	Dec. 31, 2014
STOCKHOLDERS' EQUITY
Summary of changes in restricted share and option awards outstanding		Restricted shares					Options
		Shares		Wtd. Avg.			Shares		Wtd. Avg.			Aggregate
				Grant Price					Ex. Price			Intrinsic
												Value
	December 31, 2011	71		$	37.85		292		$	25.15		$	1,110
	Granted	29		24.16			63		24.16			302
	Vested or Exercised	(44	)	37.61			(11	)	6.49			(247		)
	Forfeited	(6	)	28.55			(3	)	(20.19		)	(147		)
	December 31, 2012	50		$	31.35		341		$	25.62		1,136
	Granted	58		20.29			68		20.71			560
	Vested or Exercised	(8	)	19.57			(2	)	12.29			(33		)
	Forfeited	—		—			(24	)	(30.29		)	(1,422		)
	December 31, 2013	100		$	24.12		383		$	24.52		1,697
	Granted	61		23.27			70		24.28			327
	Vested or Exercised	(39	)	27.35			(13	)	2.87			(339		)
	Forfeited	—		—			(13	)	(24.57		)	(696		)
	December 31, 2014	122		$	22.68		427		$	24.89		1,734


Summary of information about stock options		Options Outstanding							Options Exercisable
	Range of	Shares		Wtd. Avg.		Wtd. Avg.			Shares		Wtd. Avg.		Wtd. Avg.
	Exercise			Remaining		Exercise					Remaining		Exercise
	Price			Contractual		Price					Contractual		Price
				Life							Life
	$0.00-20.00	116		2.51		$	19.41		106		2.25		$	19.40
	$20.01-30.00	214		7.60		$	22.91		80		5.38		$	22.62
	Over $30.00	97		4.68		$	35.88		87		4.68		$	35.80
		427		5.55		$	24.89		273		3.95		$	25.59


Schedule of exercisable options and related information		2014			2013			2012
	Exercisable at end of year	273			259			240
	Weighted average price	$	25.59		$	24.89		$	24.33

	Weighted average fair value of options granted during the year	$	11.61		$	9.59		$	10.92


Schedule of unvested options		Shares		Wtd. Avg.
		Shares		Ex. Price
	December 31, 2013	124		$	23.77
	Vested	38		25.08
	Granted	70		24.28
	Forfeited	(2	)	(25.75		)
	December 31, 2014	154		$	23.65


Schedule of assumptions used in determining the fair value option awards	Grant date	Equivalent		Equivalent		Implied
	Grant date	interest rate		volatility		expected lives
	March 17, 2014	2.68	%	40.00	%	8.32

COMMITMENTS_AND_CONTINGENCIES_

COMMITMENTS AND CONTINGENCIES (Tables)	12 Months Ended
	Dec. 31, 2014
COMMITMENTS AND CONTINGENCIES
Schedule of minimum rental payments	2015	$	6,841
	2016	4,230
	2017	2,464
	2018	1,080
	2019	304
	Thereafter	18
	Total	$	14,937

SEGMENT_DATA_Tables

SEGMENT DATA (Tables)	12 Months Ended
SEGMENT DATA (Tables)	Dec. 31, 2014
SEGMENT DATA
Summary of segment data		Year Ended December 31,
		2014			2013			2012
	Net service revenues
	Home Health
	Visiting Nurse	$	380,788		$	263,789		$	251,645
	Personal Care	112,497			92,927			88,975
	Healthcare Innovations	2,544			196			—
		$	495,829		$	356,912		$	340,620
	Operating income
	Home Health
	Visiting Nurse	$	46,224		$	29,533		$	37,104
	Personal Care	12,968			11,599			11,758
	Healthcare Innovations	(13		)	(482		)	—
	Unallocated	(34,537		)	(25,857		)	(20,909		)
		$	24,642		$	14,793		$	27,953
	Identifiable assets
	Home Health
	Visiting Nurse	$	259,521		$	257,315
	Personal Care	67,238			56,885
	Healthcare Innovations	9,287			9,642
	Unallocated	21,442			24,942
		$	357,488		$	348,784
	Identifiable liabilities
	Home Health
	Visiting Nurse	$	28,180		$	34,973
	Personal Care	19,498			5,520
	Healthcare Innovations	180			645
	Unallocated	76,438			89,936
		$	124,296		$	131,074
	Noncontrolling Interest - Redeemable
	Healthcare Innovations	$	3,639		$	3,639

	Capital expenditures
	Home Health
	Visiting Nurse	$	465		$	764		$	680
	Personal Care	149			267			648
	Unallocated	618			1,471			1,099
		$	1,232		$	2,502		$	2,427
	Depreciation and amortization
	Home Health
	Visiting Nurse	$	1,250		$	1,004		$	1,004
	Personal Care	271			224			156
	Unallocated	2,582			1,634			1,392
		$	4,103		$	2,862		$	2,552

ACQUISITIONS_Tables

ACQUISITIONS (Tables)	12 Months Ended
	Dec. 31, 2014
ACQUISITIONS
Summary of estimated fair values of the assets acquired and liabilities assumed		Final Purchase			Preliminary			Change
		Price Allocation			Purchase Price
					Allocation
	Accounts Receivable	$	11,330		$	16,237		$	(4,907	)
	Property, plant & equipment	2,254			2,276			(22		)
	Other assets	2,497			2,933			(436		)
	Deferred tax assets	5,720			—			5,720
	Goodwill	43,748			44,096			(348		)
	Other intangibles	31,750			33,390			(1,640		)
	Assets acquired	97,299			98,932			(1,633		)
	Liabilities assumed	(20,742		)	(22,375		)	1,633
	Net assets acquired	$	76,557		$	76,557		$	—

QUARTERLY_FINANCIAL_DATA_UNAUD1

QUARTERLY FINANCIAL DATA - (UNAUDITED) (Tables)	12 Months Ended
QUARTERLY FINANCIAL DATA - (UNAUDITED) (Tables)	Dec. 31, 2014
QUARTERLY FINANCIAL DATA - (UNAUDITED)
Summary of quarterly financial data		2014											2013
		Dec. 31		Sept. 30			Jun. 30			Mar. 31			Dec. 31			Sept. 30			Jun. 30			Mar. 31
	Net service revenues	$	124,756	$	125,540		$	125,193		$	120,340		$	96,588		$	88,471		$	86,400		$	85,453
	Gross margin	58,366		59,019			59,636			54,813			45,006			41,096			40,254			40,008
	Income from continuing operations attributable to Almost Family, Inc.	4,747		3,820			4,025			1,343			578			2,315			2,581			3,310
	Discontinued operations	1		(39		)	(64		)	(70		)	(250		)	(186		)	(59		)	(63		)
	Net income attributable to Almost Family, Inc.	$	4,748	$	3,781		$	3,961		$	1,273		$	328		$	2,129		$	2,522		$	3,247

	Average shares outstanding
	Basic	9,352		9,347			9,338			9,293			9,308			9,302			9,270			9,254
	Diluted	9,474		9,443			9,431			9,426			9,401			9,348			9,348			9,338

	Net income attributable to Almost Family, Inc. per share
	Basic	$	0.5	$	0.4		$	0.42		$	0.14		$	0.03		$	0.23		$	0.27		$	0.35
	Diluted	$	0.49	$	0.4		$	0.42		$	0.14		$	0.02		$	0.23		$	0.27		$	0.35

SUMMARY_OF_SIGNIFICANT_ACCOUNT3

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details) (SunCrest and its subsidiaries)	0 Months Ended
	Dec. 06, 2013
	Agency
SunCrest and its subsidiaries
Basis of Consolidation and Description Of Business
Number of Medicare-certified home health agencies owned and operated	66
Number of private duty agencies owned and operated	9

SUMMARY_OF_SIGNIFICANT_ACCOUNT4

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details 2) (USD $)	12 Months Ended
In Thousands, unless otherwise specified	Dec. 31, 2014	Dec. 31, 2013
Cash and Cash Equivalents
Uninsured deposits	4,183	$9,449
Office and other equipment \| Minimum
Property and equipment
Property, Plant and Equipment, Useful Life	2 years
Office and other equipment \| Maximum
Property and equipment
Property, Plant and Equipment, Useful Life	10 years
Software development
Property and equipment
Property, Plant and Equipment, Useful Life	3 years
Leasehold improvements \| Minimum
Property and equipment
Property, Plant and Equipment, Useful Life	3 years
Leasehold improvements \| Maximum
Property and equipment
Property, Plant and Equipment, Useful Life	10 years

SUMMARY_OF_SIGNIFICANT_ACCOUNT5

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details 3) (USD $)	12 Months Ended
In Thousands, unless otherwise specified	Dec. 31, 2014	Dec. 31, 2013
Goodwill
Balance at the beginning of the period	$192,489	$133,471
Additions		60,475
Disposals	34	-1,457
Balance at the end of the period	192,523	192,489
Other Intangible Assets
Balance at the beginning of the period	53,174	19,967
Additions	1,290	33,300
Amortization	-62	-93
Balance at the end of the period	54,402	53,174
Goodwill and Other Intangible Assets
Goodwill	192,523	192,489
Intangible Assets, Net (Excluding Goodwill)	54,402	53,174
Impairment loss on goodwill and other intangible assets	0
Visiting Nurse
Goodwill
Balance at the end of the period	147,368	147,368
Other Intangible Assets
Balance at the end of the period	50,232	48,965
Goodwill and Other Intangible Assets
Goodwill	147,368	147,368
Intangible Assets, Net (Excluding Goodwill)	50,232	48,965
Personal Care
Goodwill
Balance at the end of the period	37,571	37,571
Other Intangible Assets
Balance at the end of the period	4,170	4,209
Goodwill and Other Intangible Assets
Goodwill	37,571	37,571
Intangible Assets, Net (Excluding Goodwill)	4,170	4,209
Healthcare Innovations
Goodwill
Balance at the end of the period	7,584	7,550
Goodwill and Other Intangible Assets
Goodwill	7,584	7,550
Non-compete Agreements
Activity related to goodwill and other intangible assets
Estimated useful life	3 years
Other Intangible Assets
Balance at the beginning of the period	72	155
Amortization	-52	-83
Balance at the end of the period	20	72
Goodwill and Other Intangible Assets
Intangible Assets, Net (Excluding Goodwill)	20	72
Non-compete Agreements \| Visiting Nurse
Other Intangible Assets
Balance at the end of the period	10	23
Goodwill and Other Intangible Assets
Intangible Assets, Net (Excluding Goodwill)	10	23
Non-compete Agreements \| Personal Care
Other Intangible Assets
Balance at the end of the period	10	49
Goodwill and Other Intangible Assets
Intangible Assets, Net (Excluding Goodwill)	10	49
Certificates of Need and licenses
Other Intangible Assets
Balance at the beginning of the period	38,321	9,391
Additions	1,290	28,930
Balance at the end of the period	39,611	38,321
Goodwill and Other Intangible Assets
Intangible Assets, Net (Excluding Goodwill)	39,611	38,321
Certificates of Need and licenses \| Visiting Nurse
Other Intangible Assets
Balance at the end of the period	38,831	37,541
Goodwill and Other Intangible Assets
Intangible Assets, Net (Excluding Goodwill)	38,831	37,541
Certificates of Need and licenses \| Personal Care
Other Intangible Assets
Balance at the end of the period	780	780
Goodwill and Other Intangible Assets
Intangible Assets, Net (Excluding Goodwill)	780	780
Trade Names
Other Intangible Assets
Balance at the beginning of the period	14,781	10,421
Additions		4,370
Amortization	-10	-10
Balance at the end of the period	14,771	14,781
Goodwill and Other Intangible Assets
Intangible Assets, Net (Excluding Goodwill)	14,771	14,781
Trade Names \| Visiting Nurse
Other Intangible Assets
Balance at the end of the period	11,391	11,401
Goodwill and Other Intangible Assets
Intangible Assets, Net (Excluding Goodwill)	11,391	11,401
Trade Names \| Personal Care
Other Intangible Assets
Balance at the end of the period	3,380	3,380
Goodwill and Other Intangible Assets
Intangible Assets, Net (Excluding Goodwill)	$3,380	$3,380

SUMMARY_OF_SIGNIFICANT_ACCOUNT6

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details 4) (Software development, USD $)	12 Months Ended
In Thousands, unless otherwise specified	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012
Software development
Capitalized software development costs
Software development costs capitalized	$327	$647	$968

SUMMARY_OF_SIGNIFICANT_ACCOUNT7

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details 5) (USD $)	Dec. 31, 2014
In Thousands, unless otherwise specified	Dec. 31, 2014
Large-deductible workers' compensation insurance program \| Maximum
Insurance Programs
Insurance program, Company's risk per incident	$250
Self-insured employee health program \| Maximum
Insurance Programs
Insurance program, Company's risk per individual covered life	300
Professional liability
Insurance Programs
Insurance program, Company's risk per claim	0
D&O coverage \| Minimum
Insurance Programs
Insurance program, Company's risk per claim	100
D&O coverage \| Maximum
Insurance Programs
Insurance program, Company's risk per claim	$200

SUMMARY_OF_SIGNIFICANT_ACCOUNT8

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details 6) (Visiting Nurse, Florida)	Dec. 31, 2014
Visiting Nurse \| Florida
Seasonality
Segment Reporting Sales Revenue Services Net Percentage	36.00%

SUMMARY_OF_SIGNIFICANT_ACCOUNT9

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details 7) (Medicare program, USD $)	12 Months Ended
In Thousands, unless otherwise specified	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2011
Net service revenues
Segment Reporting Sales Revenue Services Net Percentage	72.00%
Period of episode	60 days
Outlier payments (as a percent)	10.00%
Percentage of reduction for sequestration	2
Increase (decrease) in revenues due to changes in estimates related to prior periods	($320)	$114	$75
Minimum
Net service revenues
Number of therapy service visits, level one threshold	6
Number of therapy service visits, level two threshold	14
Number of therapy service visits, level three threshold	20
Maximum
Net service revenues
Number of visits for avoiding low utilization payment adjustment	5

Recovered_Sheet1

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Detail 8) (USD $)	12 Months Ended
In Thousands, unless otherwise specified	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012
Concentrations
Concentrations amount, gross	83,774	75,488
Allowances	-8,880	-15,586
Accounts Receivable, Net, Current, Total	74,894	59,902
Revenue \| Revenue concentration
Concentrations
Concentrations (as a percent)	100.00%	100.00%	100.00%
Revenue \| Revenue concentration \| Medicare program
Concentrations
Concentrations (as a percent)	72.40%	71.20%	71.70%
Revenue \| Revenue concentration \| Medicaid and other government programs
Concentrations
Concentrations (as a percent)	19.60%	22.50%	22.00%
Revenue \| Revenue concentration \| Medicaid and other government programs \| OHIO
Concentrations
Concentrations (as a percent)	8.80%	11.70%	11.90%
Revenue \| Revenue concentration \| Medicaid and other government programs \| Connecticut
Concentrations
Concentrations (as a percent)	5.50%	7.10%	6.60%
Revenue \| Revenue concentration \| Medicaid and other government programs \| Kentucky
Concentrations
Concentrations (as a percent)	1.80%	2.30%	2.70%
Revenue \| Revenue concentration \| Medicaid and other government programs \| Tennessee
Concentrations
Concentrations (as a percent)	2.50%	0.20%	0.00%
Revenue \| Revenue concentration \| Medicaid and other government programs \| Florida
Concentrations
Concentrations (as a percent)	0.60%	0.70%	0.50%
Revenue \| Revenue concentration \| Medicaid and other government programs \| Others
Concentrations
Concentrations (as a percent)	0.40%	0.50%	0.30%
Revenue \| Revenue concentration \| All other payors
Concentrations
Concentrations (as a percent)	8.00%	6.30%	6.30%
Accounts receivable \| Receivable concentration
Concentrations
Concentrations (as a percent)	100.00%	100.00%
Accounts receivable \| Receivable concentration \| Medicare program
Concentrations
Concentrations (as a percent)	55.70%	56.70%
Concentrations amount, gross	46,634	42,823
Accounts receivable \| Receivable concentration \| Medicaid and other government programs
Concentrations
Concentrations (as a percent)	30.30%	25.70%
Concentrations amount, gross	25,359	19,412
Accounts receivable \| Receivable concentration \| Medicaid and other government programs \| OHIO
Concentrations
Concentrations (as a percent)	11.00%	7.80%
Concentrations amount, gross	9,239	5,925
Accounts receivable \| Receivable concentration \| Medicaid and other government programs \| Connecticut
Concentrations
Concentrations (as a percent)	4.80%	6.50%
Concentrations amount, gross	3,982	4,884
Accounts receivable \| Receivable concentration \| Medicaid and other government programs \| Kentucky
Concentrations
Concentrations (as a percent)	4.40%	3.40%
Concentrations amount, gross	3,686	2,536
Accounts receivable \| Receivable concentration \| Medicaid and other government programs \| Tennessee
Concentrations
Concentrations (as a percent)	6.70%	5.40%
Concentrations amount, gross	5,617	4,099
Accounts receivable \| Receivable concentration \| Medicaid and other government programs \| Others
Concentrations
Concentrations (as a percent)	3.40%	2.60%
Concentrations amount, gross	2,835	1,968
Accounts receivable \| Receivable concentration \| All other payors
Concentrations
Concentrations (as a percent)	14.10%	17.60%
Concentrations amount, gross	11,781	13,253

Recovered_Sheet2

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details 9) (Accounts receivable net of contractual allowances)	12 Months Ended
	Dec. 31, 2014	Dec. 31, 2013
Concentrations
Concentrations (as a percent)	100.00%	100.00%
0-90
Concentrations
Concentrations (as a percent)	62.00%	56.00%
91-180
Concentrations
Concentrations (as a percent)	22.00%	18.00%
181-365
Concentrations
Concentrations (as a percent)	15.00%	12.00%
>1 yr.
Concentrations
Concentrations (as a percent)	1.00%	14.00%
Medicare program
Concentrations
Concentrations (as a percent)	58.00%	50.00%
Medicare program \| 0-90
Concentrations
Concentrations (as a percent)	36.00%	30.00%
Medicare program \| 91-180
Concentrations
Concentrations (as a percent)	13.00%	12.00%
Medicare program \| 181-365
Concentrations
Concentrations (as a percent)	9.00%	5.00%
Medicare program \| >1 yr.
Concentrations
Concentrations (as a percent)	0.00%	3.00%
Medicaid and other government programs
Concentrations
Concentrations (as a percent)	29.00%	33.00%
Medicaid and other government programs \| 0-90
Concentrations
Concentrations (as a percent)	19.00%	18.00%
Medicaid and other government programs \| 91-180
Concentrations
Concentrations (as a percent)	6.00%	4.00%
Medicaid and other government programs \| 181-365
Concentrations
Concentrations (as a percent)	3.00%	4.00%
Medicaid and other government programs \| >1 yr.
Concentrations
Concentrations (as a percent)	1.00%	7.00%
Self Pay
Concentrations
Concentrations (as a percent)	2.00%	7.00%
Self Pay \| 0-90
Concentrations
Concentrations (as a percent)	1.00%	4.00%
Self Pay \| 91-180
Concentrations
Concentrations (as a percent)	0.00%	1.00%
Self Pay \| 181-365
Concentrations
Concentrations (as a percent)	1.00%	1.00%
Self Pay \| >1 yr.
Concentrations
Concentrations (as a percent)	0.00%	1.00%
Insurance
Concentrations
Concentrations (as a percent)	11.00%	10.00%
Insurance \| 0-90
Concentrations
Concentrations (as a percent)	6.00%	4.00%
Insurance \| 91-180
Concentrations
Concentrations (as a percent)	3.00%	1.00%
Insurance \| 181-365
Concentrations
Concentrations (as a percent)	2.00%	2.00%
Insurance \| >1 yr.
Concentrations
Concentrations (as a percent)	0.00%	3.00%

Recovered_Sheet3

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details 10) (USD $)	3 Months Ended								12 Months Ended
In Thousands, unless otherwise specified	Dec. 31, 2014	Sep. 30, 2014	Jun. 30, 2014	Mar. 31, 2014	Dec. 31, 2012	Sep. 30, 2012	Jun. 30, 2012	Mar. 31, 2012	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012
Allowance for uncollectible accounts disclosures
Allowance for uncollectible accounts	$8,880								$8,880	$15,586
Sales revenue
Net service revenues	124,756	125,540	125,193	120,340	96,588	88,471	86,400	85,453	495,829	356,912	340,620
0-90
Allowance for uncollectible accounts disclosures
Allowance for uncollectible accounts as percentage of accounts receivable									1.00%	1.00%
91-180
Allowance for uncollectible accounts disclosures
Allowance for uncollectible accounts as percentage of accounts receivable									6.00%	8.00%
181-365
Allowance for uncollectible accounts disclosures
Allowance for uncollectible accounts as percentage of accounts receivable									23.00%	33.00%
>1 yr.
Allowance for uncollectible accounts disclosures
Allowance for uncollectible accounts as percentage of accounts receivable									74.00%	92.00%
>2 yrs.
Allowance for uncollectible accounts disclosures
Allowance for uncollectible accounts as percentage of accounts receivable									100.00%	100.00%
Medicare program \| 0-90
Allowance for uncollectible accounts disclosures
Allowance for uncollectible accounts as percentage of accounts receivable									0.00%	0.00%
Medicare program \| 91-180
Allowance for uncollectible accounts disclosures
Allowance for uncollectible accounts as percentage of accounts receivable									0.00%	1.00%
Medicare program \| 181-365
Allowance for uncollectible accounts disclosures
Allowance for uncollectible accounts as percentage of accounts receivable									8.00%	9.00%
Medicare program \| >1 yr.
Allowance for uncollectible accounts disclosures
Allowance for uncollectible accounts as percentage of accounts receivable									75.00%	100.00%
Medicare program \| >2 yrs.
Allowance for uncollectible accounts disclosures
Allowance for uncollectible accounts as percentage of accounts receivable									100.00%	100.00%
Medicaid and other government programs \| 0-90
Allowance for uncollectible accounts disclosures
Allowance for uncollectible accounts as percentage of accounts receivable									1.00%	2.00%
Medicaid and other government programs \| 91-180
Allowance for uncollectible accounts disclosures
Allowance for uncollectible accounts as percentage of accounts receivable									8.00%	16.00%
Medicaid and other government programs \| 181-365
Allowance for uncollectible accounts disclosures
Allowance for uncollectible accounts as percentage of accounts receivable									31.00%	49.00%
Medicaid and other government programs \| >1 yr.
Allowance for uncollectible accounts disclosures
Allowance for uncollectible accounts as percentage of accounts receivable									66.00%	92.00%
Medicaid and other government programs \| >2 yrs.
Allowance for uncollectible accounts disclosures
Allowance for uncollectible accounts as percentage of accounts receivable									100.00%	100.00%
Self Pay \| 0-90
Allowance for uncollectible accounts disclosures
Allowance for uncollectible accounts as percentage of accounts receivable									1.00%	5.00%
Self Pay \| 91-180
Allowance for uncollectible accounts disclosures
Allowance for uncollectible accounts as percentage of accounts receivable									12.00%	36.00%
Self Pay \| 181-365
Allowance for uncollectible accounts disclosures
Allowance for uncollectible accounts as percentage of accounts receivable									51.00%	80.00%
Self Pay \| >1 yr.
Allowance for uncollectible accounts disclosures
Allowance for uncollectible accounts as percentage of accounts receivable									74.00%	87.00%
Self Pay \| >2 yrs.
Allowance for uncollectible accounts disclosures
Allowance for uncollectible accounts as percentage of accounts receivable									100.00%	100.00%
Insurance \| 0-90
Allowance for uncollectible accounts disclosures
Allowance for uncollectible accounts as percentage of accounts receivable									5.00%	5.00%
Insurance \| 91-180
Allowance for uncollectible accounts disclosures
Allowance for uncollectible accounts as percentage of accounts receivable									22.00%	22.00%
Insurance \| 181-365
Allowance for uncollectible accounts disclosures
Allowance for uncollectible accounts as percentage of accounts receivable									46.00%	38.00%
Insurance \| >1 yr.
Allowance for uncollectible accounts disclosures
Allowance for uncollectible accounts as percentage of accounts receivable									83.00%	87.00%
Insurance \| >2 yrs.
Allowance for uncollectible accounts disclosures
Allowance for uncollectible accounts as percentage of accounts receivable									100.00%	100.00%
Medicare shared savings program
Sales revenue
Net service revenues									$1,600

Recovered_Sheet4

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details 11) (USD $)	3 Months Ended								12 Months Ended
In Thousands, unless otherwise specified	Dec. 31, 2014	Sep. 30, 2014	Jun. 30, 2014	Mar. 31, 2014	Dec. 31, 2012	Sep. 30, 2012	Jun. 30, 2012	Mar. 31, 2012	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012
Earnings per Common Share
Basic weighted average outstanding shares	9,352	9,347	9,338	9,293	9,308	9,302	9,270	9,254	9,333	9,279	9,285
Dilutive effect of outstanding compensation awards									129	95	39
Diluted weighted average number of shares	9,474	9,443	9,431	9,426	9,401	9,348	9,348	9,338	9,462	9,374	9,324
Stock options excluded from computation of diluted EPS (in shares)									94	195	218
Advertising Expense									$306	$326	$316

ACCRUED_LIABILITIES_Detail

ACCRUED LIABILITIES (Detail) (USD $)	Dec. 31, 2014	Dec. 31, 2013
In Thousands, unless otherwise specified	Dec. 31, 2014	Dec. 31, 2013
ACCRUED LIABILITIES
Wages and employee benefits	$20,084	$20,755
Insurance accruals	14,217	11,602
Accrued taxes	563	1,046
Kentucky Medicaid cost report payable	1,360	3,170
Accrued professional fees and other	6,102	5,923
Total accrued liabilities	$42,326	$42,496

PROPERTY_AND_EQUIPMENT_NET_Det

PROPERTY AND EQUIPMENT, NET (Detail) (USD $)	12 Months Ended
In Thousands, unless otherwise specified	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012
Property and equipment
Property and equipment, gross	$20,669	$24,575
Less accumulated depreciation	-15,094	-16,455
Property, Plant and Equipment, Net, Total	5,575	8,120
Depreciation and amortization	3,850	2,594	2,315
Leasehold improvements
Property and equipment
Property and equipment, gross	1,367	1,448
Medical equipment
Property and equipment
Property and equipment, gross	937	1,671
Computer equipment
Property and equipment
Property and equipment, gross	9,607	14,594
Software development
Property and equipment
Property and equipment, gross	3,807	1,404
Office and other equipment
Property and equipment
Property and equipment, gross	4,502	5,071
Vehicles
Property and equipment
Property and equipment, gross	$449	$387

REVOLVING_CREDIT_FACILITY_Deta

REVOLVING CREDIT FACILITY (Details) (USD $)	12 Months Ended	0 Months Ended
	Dec. 31, 2014	Feb. 12, 2015	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2011
	multiple	Feb. 12, 2015	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2011
Revolving credit facility
Company's net worth	$229,553,000		$214,071,000	$204,315,000	$206,297,000
Revolving Credit Facility
Revolving credit facility
Revolving credit limit	125,000,000
Potential future expansion of the Facility under accordion feature	175,000,000
EBITDA multiplier	3.5
Borrowing capacity permitted to be used per formula	80,000,000
Irrevocable letters of credit outstanding	7,500,000
Remaining borrowing capacity available for use	72,500,000
Minimum net worth required to be maintained	163,500,000
Revolving Credit Facility \| Subsequent event
Revolving credit facility
Term of debt instrument		5 years
Revolving credit limit		175,000,000
Potential future expansion of the Facility under accordion feature		$250,000,000
Revolving Credit Facility \| Maximum
Revolving credit facility
Percentage of acquired EBITDA which can be included in covenants calculation	50.00%
Revolving Credit Facility \| Prime rate
Revolving credit facility
Variable rate basis	Bank's prime rate plus a margin
Actual interest rate margin (as a percent)	1.25%
Weighted average interest rate (as a percent)	2.70%		5.00%
Revolving Credit Facility \| Prime rate \| Minimum
Revolving credit facility
Interest rate margin per debt instrument (as a percent)	1.25%
Revolving Credit Facility \| Prime rate \| Maximum
Revolving credit facility
Interest rate margin per debt instrument (as a percent)	2.25%
Revolving Credit Facility \| LIBOR
Revolving credit facility
Variable rate basis	LIBOR plus a margin
Actual interest rate margin (as a percent)	2.25%
Revolving Credit Facility \| LIBOR \| Minimum
Revolving credit facility
Interest rate margin per debt instrument (as a percent)	2.25%
Revolving Credit Facility \| LIBOR \| Minimum \| Subsequent event
Revolving credit facility
Interest rate margin per debt instrument (as a percent)		1.75%
Revolving Credit Facility \| LIBOR \| Maximum
Revolving credit facility
Interest rate margin per debt instrument (as a percent)	3.25%
Revolving Credit Facility \| LIBOR \| Maximum \| Subsequent event
Revolving credit facility
Interest rate margin per debt instrument (as a percent)		3.00%

INCOME_TAXES_Details

INCOME TAXES (Details) (USD $)	12 Months Ended
INCOME TAXES (Details) (USD $)	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012
INCOME TAXES
Uncertain tax positions	$1,186,000
Provision for income taxes
Federal - current	2,829,000	3,557,000	6,113,000
State and local - current	1,182,000	364,000	1,181,000
Deferred	5,500,000	2,099,000	3,753,000
Income Tax Expense (Benefit), Total	9,511,000	6,020,000	11,047,000
Reconciliation of the statutory to the effective rate
Tax provision using statutory rate (as a percent)	35.00%	35.00%	35.00%
State and local taxes, net of Federal benefit (as a percent)	4.70%	5.70%	4.10%
Valuation allowance (as a percent)	1.00%	-0.60%	-0.60%
Noncontrolling interest related	0.40%	0.50%	0.00%
Other, net (as a percent)	-0.10%	1.30%	0.70%
Effective Income Tax Rate Reconciliation, Percent, Total	41.00%	41.90%	39.20%
Increase in valuation allowance due to a change in expected realizability of deferred tax assets for states operating loss carry-forwards	200,000
Deferred tax assets
Non-deductible reserves and allowances	9,853,000	10,760,000
Insurance accruals	3,174,000	2,408,000
Net operating loss carryforwards	1,484,000	1,160,000
Deferred tax assets, gross	14,511,000	14,328,000
Valuation allowance	-1,746,000	-1,521,000
Deferred tax assets	12,765,000	12,807,000
Deferred tax liabilities
Goodwill & intangibles	23,038,000	17,093,000
Accelerated depreciation	-1,007,000	-1,494,000
Deferred tax liabilities	-24,045,000	-18,587,000
Net deferred tax liabilities	-11,280,000	-5,780,000
Deferred tax (liabilities) assets are reflected in the accompanying balance sheet as:
Deferred tax assets classified as current assets	12,230,000	12,224,000
Long-term liabilities	-23,510,000	-18,004,000
Net deferred tax liabilities	-11,280,000	-5,780,000
Book value of goodwill not deductible for tax purposes	108,700,000	109,000,000
Changes in unrecognized tax benefits
Increases related to positions taken in the current year	1,186,000
Balance	1,186,000
State
Operating loss carry-forwards
Net operating loss carry-forwards	29,800,000
Valuation allowance	$25,900,000

STOCKHOLDERS_EQUITY_Details

STOCKHOLDERS' EQUITY (Details) (USD $)	0 Months Ended	12 Months Ended
In Thousands, except Share data, unless otherwise specified	Mar. 01, 2013	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2010
Options Outstanding
Shares		427,000
Wtd. Avg. Remaining Contractual Life		5 years 6 months 18 days
Wtd. Avg. Exercise Price (in dollars per share)		$24.89
Options Exercisable
Shares		273,000
Wtd. Avg. Remaining Contractual Life		3 years 11 months 12 days
Wtd. Avg. Exercise Price (in dollars per share)		$25.59
Assumptions used in determining the fair value option awards
Dividend yield		0.00%
Dividend payouts		$0
Additional information
Unrecognized compensation cost		2,238
Weighted-average recognition period		2 years 5 months 23 days
Range of exercise price per share from $0.00 to $20.01
Share-based Compensation Arrangement by Share-based Payment Award, Options, Additional Disclosures [Abstract]
Exercise price, low end of range (in dollars per share)		$0
Exercise price, high end of range (in dollars per share)		$20
Options Outstanding
Shares		116,000
Wtd. Avg. Remaining Contractual Life		2 years 6 months 4 days
Wtd. Avg. Exercise Price (in dollars per share)		$19.41
Options Exercisable
Shares		106,000
Wtd. Avg. Remaining Contractual Life		2 years 3 months
Wtd. Avg. Exercise Price (in dollars per share)		$19.40
Range of exercise price per share from $20.01 to $30.00
Share-based Compensation Arrangement by Share-based Payment Award, Options, Additional Disclosures [Abstract]
Exercise price, low end of range (in dollars per share)		$20.01
Exercise price, high end of range (in dollars per share)		$30
Options Outstanding
Shares		214,000
Wtd. Avg. Remaining Contractual Life		7 years 7 months 6 days
Wtd. Avg. Exercise Price (in dollars per share)		$22.91
Options Exercisable
Shares		80,000
Wtd. Avg. Remaining Contractual Life		5 years 4 months 17 days
Wtd. Avg. Exercise Price (in dollars per share)		$22.60
Range of exercise price per share over $30.00
Share-based Compensation Arrangement by Share-based Payment Award, Options, Additional Disclosures [Abstract]
Exercise price, low end of range (in dollars per share)		$30
Options Outstanding
Shares		97,000
Wtd. Avg. Remaining Contractual Life		4 years 8 months 12 days
Wtd. Avg. Exercise Price (in dollars per share)		$35.88
Options Exercisable
Shares		87,000
Wtd. Avg. Remaining Contractual Life		4 years 8 months 5 days
Wtd. Avg. Exercise Price (in dollars per share)		$35.80
2000 Employee Stock Option Plan
Stock-based compensation
Shares available for future grant		0
2007 Stock and Incentive Compensation Plan
Stock-based compensation
Shares available for future grant		0
2013 Stock and Incentive Plan
Stock-based compensation
Shares available for future grant		536,000
Restricted shares
Changes in option awards outstanding, Shares
Balance at the beginning of the period (in shares)		100,000	50,000	71,000
Granted (in shares)		61,000	58,000	29,000
Vested or Exercised (in shares)		-39,000	-8,000	-44,000
Forfeited (in shares)				-6,000
Balance at the end of the period (in shares)		122,000	100,000	50,000
Changes in option awards, Wtd Avg Ex. Price
Balance at the beginning of the period (in dollars per share)		$24.12	$31.35	$37.85
Granted (in dollars per share)		$23.27	$20.29	$24.16
Vested or Exercised (in dollars per share)		$27.35	$19.57	$37.61
Forfeited (in dollars per share)				$28.55
Balance at the end of the period (in dollars per share)		$22.68	$24.12	$31.35
Changes in unvested options, Shares
Granted (in shares)		61,000	58,000	29,000
Changes in unvested options, Wtd Avg Ex. Price
Granted (in dollars per share)		$23.27	$20.29	$24.16
Restricted shares \| 2007 Stock and Incentive Compensation Plan
Stock-based compensation
Number of shares of common stock that can be purchased		200,000
Number of anniversaries		3 years
Changes in option awards outstanding, Shares
Balance at the end of the period (in shares)		162,000
Restricted shares \| 2013 Stock and Incentive Plan
Stock-based compensation
Number of shares of common stock that can be purchased		200,000
Number of anniversaries		3 years
Number of shares awarded		86,000
Option awards
Stock-based compensation
Vesting period		10 years
Changes in option awards outstanding, Shares
Balance at the beginning of the period (in shares)		383,000	341,000	292,000
Granted (in shares)		70,000	68,000	63,000
Vested or Exercised (in shares)		-13,000	-2,000	-11,000
Forfeited (in shares)		-13,000	-24,000	-3,000
Balance at the end of the period (in shares)		427,000	383,000	341,000
Changes in option awards, Wtd Avg Ex. Price
Balance at the beginning of the period (in dollars per share)		$24.52	$25.62	$25.15
Granted (in dollars per share)		$24.28	$20.71	$24.16
Vested or Exercised (in dollars per share)		$2.87	$12.29	$6.49
Forfeited (in dollars per share)		($24.57)	($30.29)	($20.19)
Balance at the end of the period (in dollars per share)		$24.89	$24.52	$25.62
Share-based Compensation Arrangement by Share-based Payment Award, Options, Additional Disclosures [Abstract]
Balance at the beginning of the period		1,697	1,136		1,110
Granted		327	560	302
Vested or Exercised		-339	-33	-247
Forfeited		-696	-1,422	-147
Balance at the end of the period		1,734	1,697	1,136	1,110
Exercisable at end of year (in shares)		273	259	240
Weighted average price (in dollars per share)		$25.59	$24.89	$24.33
Weighted average fair value of options granted during the year (in dollars per share)		$11.61	$9.59	$10.92
Changes in unvested options, Shares
Balance at the beginning of the period (in shares)		124,000
Vested (in shares)		38,000
Granted (in shares)		70,000	68,000	63,000
Forfeited (in shares)		-2,000
Balance at the end of the period (in shares)		154,000	124,000
Changes in unvested options, Wtd Avg Ex. Price
Balance at the beginning of the period (in dollars per share)		$23.77
Vested (in dollars per share)		$25.08
Granted (in dollars per share)		$24.28	$20.71	$24.16
Forfeited (in dollars per share)		($25.75)
Balance at the end of the period (in dollars per share)		$23.65	$23.77
Assumptions used in determining the fair value option awards
Equivalent interest rate (as a percent)	2.68%
Equivalent volatility (as a percent)	40.00%
Implied expected lives	8 years 3 months 26 days
Additional information
Total fair value of option shares vested		$370	$375
Option awards \| 2000 Employee Stock Option Plan
Stock-based compensation
Number of shares of common stock that can be purchased		1,000,000
Term of options		10 years
Shares available for future grant		0
Changes in option awards outstanding, Shares
Balance at the end of the period (in shares)		103,000
Option awards \| 2007 Stock and Incentive Compensation Plan
Stock-based compensation
Number of shares of common stock that can be purchased		500,000
Term of options		10 years
Option share awards vest annually in increments (as a percent)		25.00%
Vesting period		4 years
Changes in option awards outstanding, Shares
Balance at the end of the period (in shares)		245,000
Option awards \| 2013 Stock and Incentive Plan
Stock-based compensation
Number of shares of common stock that can be purchased		700,000
Term of options		10 years
Option share awards vest annually in increments (as a percent)		25.00%
Vesting period		4 years
Number of shares awarded		78,000

STOCKHOLDERS_EQUITY_Details_2

STOCKHOLDERS' EQUITY (Details 2) (USD $)	12 Months Ended
In Millions, except Share data, unless otherwise specified	Dec. 31, 2012	Dec. 31, 2014
Directors Deferred Compensation Plan
Number of shares redeemed	72,000
Share redemption amount	$1.70
Employee stock purchase plan
Employee Stock Purchase Plan
Number of shares of common stock authorized for issuance		300,000
Number of shares of common stock available		300,000

RETIREMENT_PLAN_Details

RETIREMENT PLAN (Details) (USD $)	12 Months Ended
In Thousands, unless otherwise specified	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012
RETIREMENT PLAN
Employer matching contribution (as a percent)	0.25%
Voluntary contribution by participating employee (as a percent)	5.00%
Requisite service period for eligibility of employer matching contribution	1 year
Retirement plan expense	$910	$550	$509

COMMITMENTS_AND_CONTINGENCIES_1

COMMITMENTS AND CONTINGENCIES (Detail) (USD $)	12 Months Ended
In Thousands, unless otherwise specified	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012
COMMITMENTS AND CONTINGENCIES
Operating Leases, Rent Expense	$12,846	$8,619	$8,656
Operating Leases, Future Minimum Payments Due, Next Twelve Months	6,841
Operating Leases, Future Minimum Payments, Due in Two Years	4,230
Operating Leases, Future Minimum Payments, Due in Three Years	2,464
Operating Leases, Future Minimum Payments, Due in Four Years	1,080
Operating Leases, Future Minimum Payments, Due in Five Years	304
Operating Leases, Future Minimum Payments, Due Thereafter	18
Total	$14,937

SEGMENT_DATA_Details

SEGMENT DATA (Details) (USD $)	3 Months Ended								12 Months Ended
In Thousands, unless otherwise specified	Dec. 31, 2014	Sep. 30, 2014	Jun. 30, 2014	Mar. 31, 2014	Dec. 31, 2012	Sep. 30, 2012	Jun. 30, 2012	Mar. 31, 2012	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012
									division
									segment
SEGMENT DATA
Number of divisions									2
Number of reportable segments									3
Segment data
Net service revenues	$124,756	$125,540	$125,193	$120,340	$96,588	$88,471	$86,400	$85,453	$495,829	$356,912	$340,620
Operating income									24,642	14,793	27,953
Identifiable assets	357,488								357,488	348,784
Identifiable liabilities	124,296								124,296	131,074
Noncontrolling Interest - Redeemable	3,639								3,639	3,639
Capital expenditures									1,232	2,502	2,427
Depreciation and amortization									4,103	2,862	2,552
Corporate expenses
Segment data
Operating income									-34,537	-25,857	-20,909
Identifiable assets	21,442								21,442	24,942
Identifiable liabilities	76,438								76,438	89,936
Capital expenditures									618	1,471	1,099
Depreciation and amortization									2,582	1,634	1,392
Visiting Nurse
Segment data
Net service revenues									380,788	263,789	251,645
Operating income before corporate expenses									46,224	29,533	37,104
Identifiable assets	259,521								259,521	257,315
Identifiable liabilities	28,180								28,180	34,973
Capital expenditures									465	764	680
Depreciation and amortization									1,250	1,004	1,004
Personal Care
Segment data
Net service revenues									112,497	92,927	88,975
Operating income before corporate expenses									12,968	11,599	11,758
Identifiable assets	67,238								67,238	56,885
Identifiable liabilities	19,498								19,498	5,520
Capital expenditures									149	267	648
Depreciation and amortization									271	224	156
Healthcare Innovations Segment
Segment data
Net service revenues									2,544	196
Operating income before corporate expenses									-13	-482
Identifiable assets	9,287								9,287	9,642
Identifiable liabilities	180								180	645
Noncontrolling Interest - Redeemable	3,639								3,639	3,639
Medicare program
Segment data
Segment revenues (as a percent)	72.00%								72.00%
Medicare program \| Visiting Nurse
Segment data
Segment revenues (as a percent)	94.00%								94.00%
Medicaid and other government programs \| Personal Care
Segment data
Segment revenues (as a percent)	79.00%								79.00%
Medicare shared savings program
Segment data
Net service revenues									$1,600

DISCONTINUED_OPERATIONS_Detail

DISCONTINUED OPERATIONS (Details) (Visiting Nurse, Alabama locations, Discontinued Operations)	3 Months Ended
	Jun. 30, 2013
	location
Visiting Nurse \| Alabama locations \| Discontinued Operations
Discontinued Operations
Numbers of locations sold	2

ACQUISITIONS_Details

ACQUISITIONS (Details) (USD $)	12 Months Ended			0 Months Ended
	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012	Dec. 06, 2013	Oct. 04, 2013	Jul. 17, 2013
	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012	Agency	Oct. 04, 2013	Agency
Acquisitions
Period over which goodwill and other intangible assets are expected to be deductible for tax purposes	15 years
Cash paid	$969,000	$88,465,000	$536,000
Goodwill	192,523,000	192,489,000	133,471,000
SunCrest and its subsidiaries
Acquisitions
Number of Medicare-certified home health agencies owned and operated				66
Number of private duty agencies owned and operated				9
Cash consideration				75,100,000
Purchase price				76,600,000
Note payable				1,500,000
Acquired cash balances				2,200,000
Annual tax deductible amount of goodwill and intangibles acquired	4,300,000
Accounts receivable				11,330,000
Property, plant & equipment				2,254,000
Other assets				2,497,000
Deferred tax assets				5,720,000
Goodwill				43,748,000
Other intangibles				31,750,000
Assets acquired				97,299,000
Liabilities assumed				-20,742,000
Net assets acquired				76,557,000
SunCrest and its subsidiaries \| Preliminary Purchase Price Allocation
Acquisitions
Accounts receivable				16,237,000
Property, plant & equipment				2,276,000
Other assets				2,933,000
Goodwill				44,096,000
Other intangibles				33,390,000
Assets acquired				98,932,000
Liabilities assumed				-22,375,000
Net assets acquired				76,557,000
SunCrest and its subsidiaries \| Effect of reclassifications
Acquisitions
Accounts receivable				-4,907,000
Property, plant & equipment				-22,000
Other assets				-436,000
Deferred tax assets				5,720,000
Goodwill				-348,000
Other intangibles				-1,640,000
Assets acquired				-1,633,000
Liabilities assumed				1,633,000
Imperium Health Management LLC
Acquisitions
Purchase price					5,800,000
Interest acquired (as a percent)					61.50%
Imperium investment available for general purposes					3,000,000
Noncontrolling interest percentage					38.50%
Indiana Home Care Network
Acquisitions
Number of Medicare-certified home health agencies owned and operated						6
Purchase price						12,500,000
Common stock issued						500,000
Goodwill						9,900,000
Other intangibles						$1,800,000

ACQUISITIONS_Details_2

ACQUISITIONS (Details 2)	12 Months Ended
	Dec. 31, 2012
	item
ACQUISITIONS
Number of acquisitions	2

QUARTERLY_FINANCIAL_DATA_UNAUD2

QUARTERLY FINANCIAL DATA - (UNAUDITED) (Detail) (USD $)	3 Months Ended								12 Months Ended
In Thousands, except Per Share data, unless otherwise specified	Dec. 31, 2014	Sep. 30, 2014	Jun. 30, 2014	Mar. 31, 2014	Dec. 31, 2012	Sep. 30, 2012	Jun. 30, 2012	Mar. 31, 2012	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012
QUARTERLY FINANCIAL DATA - (UNAUDITED)
Net service revenues	$124,756	$125,540	$125,193	$120,340	$96,588	$88,471	$86,400	$85,453	$495,829	$356,912	$340,620
Gross margin	58,366	59,019	59,636	54,813	45,006	41,096	40,254	40,008	231,835	166,364	163,937
Income from continuing operations attributable to Almost Family, Inc.	4,747	3,820	4,025	1,343	578	2,315	2,581	3,310	13,524	8,048	17,284
Discontinued operations	1	-39	-64	-70	-250	-186	-59	-63	-172	-558	482
Net income attributable to Almost Family, Inc.	$4,748	$3,781	$3,961	$1,273	$328	$2,129	$2,522	$3,247	$13,763	$8,226	$17,284
Average shares outstanding
Basic (in shares)	9,352	9,347	9,338	9,293	9,308	9,302	9,270	9,254	9,333	9,279	9,285
Diluted (in shares)	9,474	9,443	9,431	9,426	9,401	9,348	9,348	9,338	9,462	9,374	9,324
Net income attributable to Almost Family, Inc. per share
Basic (in dollars per share)	$0.50	$0.40	$0.42	$0.14	$0.03	$0.23	$0.27	$0.35	$1.47	$0.89	$1.86
Diluted (in dollars per share)	$0.49	$0.40	$0.42	$0.14	$0.02	$0.23	$0.27	$0.35	$1.45	$0.88	$1.85

Subsequent_Events_Details

Subsequent Events (Details) (USD $)	12 Months Ended	0 Months Ended
In Millions, unless otherwise specified	Dec. 31, 2014	Jan. 29, 2015	Feb. 24, 2015
	Dec. 31, 2014	Jan. 29, 2015	location
Will Care Member
Subsequent Events
Revenue for the year before acquisition	$72
Subsequent event \| NavHealth, Inc \| Maximum
Subsequent Events
Investment in noncontrolling interest		2
Expects \| Will Care Member \| Minimum
Subsequent Events
Purchase price	46
Expects \| Will Care Member \| Maximum
Subsequent Events
Purchase price	$53
New York
Subsequent Events
Number of locations acquired			11
Connecticut
Subsequent Events
Number of locations acquired			3
OHIO
Subsequent Events
Number of locations acquired			1

SCHEDULE_II_VALUATION_AND_QUAL1

SCHEDULE II - VALUATION AND QUALIFYING ACCOUNTS (Details) (USD $)	12 Months Ended
In Thousands, unless otherwise specified	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012
Allowance for uncollectible accounts:
Balance at Beginning of Period	$15,586	$5,236	$6,664
Additions/(Deductions) Charged to Costs and Expenses	9,413	5,526	2,825
Additions/(Deductions) Charged to Other Accounts		8,910	46
Deductions	-16,119	-4,086	-4,299
Balance at End of Period	$8,880	$15,586	$5,236